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Résumé 
Fond : Le substrat de fibrillation auriculaire (FA) vagale et celui secondaire à remodelage 
par tachycardie auriculaire (RTA) partagent beaucoup des caractéristiques : période 
réfractaire efficace (PRE) réduite, hétérogénéité accrue de PRE et quelques mécanismes 
moléculaires communs. Cette étude a comparé les 2 substrats à une abréviation comparable 
de PRE.  
Méthodes : Chez chacun de 6 chiens de groupe de stimulation vagal (SV), les paramètres 
de stimulation cervicale bilatérale de nerves vagaux ont été ajustés pour produire la même 
PRE moyenne (calculé à 8 sites des oreillettes gauche et droite) avec 6 chiens de groupe de 
RTA assorti à sexe et poids. Des paramètres électrophysiologiques, la durée moyenne de la 
fibrillation auriculaire (DAF) et les fréquences dominantes (FD) locales ont étés calculés.  
Résultats : En dépit des PREs assorties (SV: 80±12msec contre RTA: 79±12msec) la DAF 
était plus longue (*), l’hétérogénéité de conduction était plus élevée (*), la FD était plus 
rapide (*) et la variabilité de FD plus grande (*) chez les chiens SV. Les zones de 
maximum FD qui reflètent les zones d’origine de FA étaient à côté de ganglions autonomes 
chez les chiens SV.  
Conclusions : Pour un PRE atriale comparable, la FA secondaire à SV est plus rapide et 
plus persistante que la FA avec un substrat de RTA. Ces résultats sont consistants avec des 
modèles de travail suggérant que l'hyperpolarisation SV-induite contribue de façon 
important à la stabilisation et à l'accélération des rotors qui maintiennent la FA. La 
similitude de la distribution de FD du groupe vagal avec la distribution des lésions 
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d’ablation après cartographie des électrogrammes atriales fragmentés suggère des nouvelles 
techniques d’ablation. La distribution des FD entre le SV et le RTA fournit de nouvelles 
idées au sujet de possible rémodelage neuroreceptorial et indique des différences 
importantes entre ces substrats de FA superficiellement semblables. 
 
Mots-clés : fibrillation auriculaire, période réfractaire effective, stimulation vagal, ganglion 
cardiaque, remodelage par tachycardie auriculaire, fréquence dominante, récepteurs 
muscariniques, vitesse de conduction. 
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Abstract 
Background: Vagal nerve stimulation (VS) and atrial tachycardia remodeled (ATR) atrial 
fibrillation (AF) substrates share many features: reduced effective refractory period (ERP), 
increased ERP heterogeneity and some common molecular mechanisms. This study 
compared VS and ATR substrates at comparable ERP abbreviation.  
Methods: In each of 6 VS dogs, bilateral cervical VS parameters were adjusted to produce 
the same mean ERP as a sex and weight matched ATR dog. Electrophysiological 
parameters, mean duration of AF (DAF) and local dominant frequencies (DF) were 
determined (before (CTL) and after VS in VS dogs). 
Results: Despite matched ERPs (VG: 80±12msec vs ATR: 79±12msec) DAF was greater 
(*), conduction heterogeneity was greater (*), DF was faster (*) and DF variability greater 
(*) in VS dogs. AF drivers reflected by maximum DF zones were adjacent to autonomic 
ganglia in VS dogs; there was a tendency (p<0.07) to faster driver zones in the left atrium 
comparing to the right in ATR dogs. 
Conclusions: For a comparable atrial ERP, VS AF is faster and more persistent than AF 
with an ATR substrate. These results are consistent with modeling work suggesting that 
VS-induced hyperpolarization is an important contributor to AF-maintaining rotor 
stabilization and acceleration. Similarities in DF distribution in VS dogs with distribution 
of ablation lesions performed after Complex Fractionated Atrial Electrograms mapping 
suggests new curative ablation methods. DF distribution differences between VS and ATR 
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provides new ideas about possible neuroreceptorial remodeling and indicates important 
differences between these superficially similar AF substrates. 
 
Keywords: Atrial fibrillation, atrial tachycardia remodeling, vagal stimulation, dominant 
frequencies, effective refractory period, cardiac ganglia, muscarinic receptors, conduction 
velocity 
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1. Introduction 
 
1.1 Atrial Fibrillation 
 
1.1.1 Definition 
Atrial fibrillation (AF) is a supraventricular tachycardia characterized by erratic and 
uncoordinated electrical activation of the atria causing deterioration of atrial mechanical 
function and irregular heart rhythm1, 2. On the electrocardiogram, AF is characterized by the 
substitution of the normally present P waves with fibrillatory (f) waves that conduct 
variably to the ventricles, creating the characteristic “irregularly irregular” heart rhythm of 
AF.  
The f waves are small, irregular baseline undulations of variable amplitude and 
morphology at a rate of 350-600 beats/min3. Atrial dimensions and underlying heart disease 
are the main factors influencing the amplitude of f waves. Occasionaly, electrical activity is 
not recognizable on the ECG, but only by atrial endocardial leads recording electrical 
activity of even higher frequency. It is believed that f waves don’t represent total atrial 
activity but depict only the larger vectors generated by the variable electrical atrial 
activation at any given moment3. However, if each atrial impulse were conducted to the 
ventricle the extremely rapid ventricular rate would lead to ineffective cardiac contraction 
and sudden death4. The filtering properties of the atrioventricular (AV) node, which has a 
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limited impulse-carrying capacity, prevent such an event. Thus, the ventricular response to 
AF depends on the interaction between atrial rate and filtering AV node function, the level 
of vagal and sympathetic tone, the presence or absence of accessory pathways, and the 
action of drugs1, 4.  
Although AF can occur in patients without any evident heart problems (lone AF), it 
is generally associated with structural heart diseases such as congestive heart failure, 
valvular disease, ischemic heart disease, pericardial diseases, congenital defects and 
hypertensive or other cardiomyopathies. Atrial dilation and increased atrial pressure are the 
most plausible causes of AF promotion in such patients. However, the precise mechanistic 
links are incompletely defined4. Non-cardiac causes include electrolyte disturbances, 
ethanol intoxication, thyroid dysfunction, pulmonary disease, septic disease or febrile 
illnesses5. 
 
1.1.2 Classification 
Various classifications have been proposed. According to ACC/AHA/ESC 
guidelines “the clinician should distinguish a first-detected episode of AF (fig. 1), 
recognizing that there may be uncertainty about the duration of the episode and about 
previous undetected episodes”1. If the patient had 2 or more episodes AF is recurrent. If an 
episode lasts longer than 7 days then AF is characterized as persistent. If AF terminates 
spontaneously or even after pharmacological or electrical cardioversion in less than 7 days 
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time then it should be classified as paroxysmal. AF lasting longer than a year becomes 
permanent. 
 
Fig. 1  Patterns of AF. Paroxysmal AF for episodes lasting less than 7 days, persistent AF 
for episodes lasting between 7 days and one year and permanent AF for episodes greater 
than a year (adapted from Fuster et al1) 
 
These categories are not mutually exclusive. A patient can present several times 
with paroxysmal and occasionally persistent AF and vice versa. It is practical to categorize 
the patient according to the most frequent presentation.  
The term “lone AF” applies to arrhythmic episodes in young individuals (generally 
<60 years old) without evidence of cardiopulmonary disease1, 6. It represents one of the 
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most intriguing forms of AF, comporting interesting pathophysiological implications. It 
generally has a favorable prognosis.  
 
1.1.3 Epidemiology and prognosis 
Prevalence of a disease is defined as the proportion of a population affected by the 
disease at a point in time. The estimated prevalence of AF is 0.4% to 1% in the general 
population1, 7. It increases to 9% in subjects 80 years or older. AF prevalence is higher in 
men when compared to women at all ages. Nevertheless, due to the higher mean age, 
women comprise a larger proportion of the older groups8, 9.  
AF prevalence is expected to increase proportionally with the increase of mean age 
of population. In USA the percentage of subjects older than 65 years is estimated to 
increase substantially by the year 2050 to more than 20% of the general population9. 
Considering that 75% of patients with AF are 65 years or older and the median age of U.S 
patients with AF is 75 years7-9, we would expect a considerable rise of AF prevalence in 
USA and proportionally in other countries with similar lifestyle. 
The incidence of a disease is the rate at which new cases present in a population 
during a specified time period. In prospective studies the incidence of AF increases from 
less than 0.1% per year in patients under 40 years to more than 1.5% in women and 2% in 
men older than 80 years old1, 10, 11. Furthermore, in the Framingham study the age-adjusted 
incidence increased in a span of less than 30 years, suggesting a greater impact of AF in the 
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near future1, 11. The lifetime risk for development of AF was 1 in 4 for individuals 40 years 
of age and older9, 12. Thus, the burden of AF in the population, being already high, increases 
from year to year, comporting increases in costs, physical damage and mortality.  
AF is associated with an increased risk of stroke, heart failure (HF) and all cause 
mortality1. In the Framingham Heart Study, it was associated with 1.5 to 1.9 fold excess 
mortality after adjustment for preexisting cardiovascular conditions. Main causes of 
mortality are thromboembolic events and/or HF.  
The ventricular rate in AF is determined by the interaction between the high atrial 
rate and the filtering function of AV node4. High ventricular rates can per se cause severe 
congestive HF after several weeks or months13, whereas high heart rate in patients with HF 
can be deleterious and increase mortality. HF promotes AF and vice versa. Patients with 
either condition that develop the alternate have a poor prognosis1. Moreover, loss of 
effective atrial contraction leads to blood stasis in the atria and formation of clots that tend 
to propagate to the brain and other vital organs. The rate of ischemic stroke among patients 
with non valvular AF averages 5% per year with a relative risk 6 times higher of that of 
people without AF1. About 36% of ischemic strokes in individuals aged 80 to 89 years old 
are attributed to AF9.  
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1.2 Mechanisms of Atrial Fibrillation 
 
1.2.1 Theories 
AF is the most common arrhythmia in clinical practice. Therefore, researchers 
focused early on this arrhythmia and theories regarding its mechanisms have been put 
forward almost 100 years ago4, 5. The principal mechanisms described were 1) the 
automatic focus activity 2) the single circuit reentry and 3) the multiple-circuit reentry. 
1.2.1.1 Rapid ectopic activity and single circuit reentry theories 
Focal activity and single circuit reentry theories include the existence of a source 
producing high frequency wavefronts that interact with the spatially variable refractory and 
conductive properties of atrial tissue. A single rapid firing focus would be expected to 
produce a regular tachycardia. However, if the atrial rate is too rapid the atria cannot 
respond in a 1:1 fashion and a chaotic atrial rhythm will result. Haissaguere et al showed 
that AF is frequently initiated by rapid focal ectopic activity coming from the pulmonary 
veins (PV)14. While PV seem the most frequent source of ectopic activity, rapid foci have 
been found also in superior vena cava (SVC), ligament of Marshall, left posterior free wall, 
crista terminalis and coronary sinus1.  
Seemingly, special conditions are necessary in order for a single-circuit reentry to 
stabilize and maintain AF. A microreentrant circuit, with exiting impulses firing at 
extremely high rates, encounters functional conduction barriers in the atria that obstacle a 
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1:1 conduction. Fibrillatory conduction can be due to spatially variable refractory periods 
or to the structural properties of atrial tissue5, 15. Schuessler et al. demonstrated in an 
isolated right atrial (RA) preparation that, with increasing concentrations of acetylcholine 
(ACh), a single, relatively stable, high frequency circuit resulted in fibrillatory 
conduction16. Studies from Mandapati et al. reinforced the concept that localized left atrial 
(LA) sources, which may be single microreentrant circuits, would be the basis for AF in 
isolated animal hearts17. Furthermore, Berenfeld et al. demonstrated in the same animal 
model that there exists a frequency in the sheep RA below which electrical activity is 
organized and above which it is disorganized like AF15. Consequently, although a dominant 
frequency (DF) of fibrillation in LA would be conducted in the RA with decreasing values, 
such frequency would be high enough to disorganize electrical propagation in RA. Similar 
DF differences between LA and RA have been observed either clinically or experimentally 
in other studies18, 19. 
1.2.1.2 Multiple-circuit reentry 
Over the past 50 years the hypothesis of multiple circuit reentry has been the 
dominant conceptual model of AF4. According to Moe and coworkers20, fractionation of 
wavefronts propagating through the atria results in multiple reentrant self- perpetuating 
wavelets. The number of wavelets at any time depends on the atrial mass, the refractory 
period and the conduction velocity (CV) in different parts of the atria. Large atrial mass, 
short refractory period and delayed conduction are conditions that increase the number of 
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wavelets favoring sustained AF. However, a sufficient number of these wave fronts must 
always find excitable tissue in order for the arrhythmia to persist. 
Based on these concepts and in subsequent experimental work Allessie and 
colleagues21, 22 developed the “leading circle” model of functional reentry. The wavelength 
(WL) is the distance travelled by the electrical impulse during the time of effective 
refractory period (ERP) and equals the product of the ERP with the CV. If the dimensions 
of the tissue involved are shorter than the WL, the presuppositions of reentry are missing, 
as the electrical impulse encounters unexcitable tissue and consequently extinguishes. 
Normal size atrium can permit only a small number of leading circles, which tend to 
extinguish. On the contrary, a dilated atrium can host multiple leading circles promoting 
sustained AF. Based on this notion, the Maze procedure was designed to divide the atrium 
into regions too small to support reentry23. The great efficacy of this procedure 
strengthened the multiple circuit reentry concept5. Additionally, interventions that decrease 
WL such as vagal stimulation (VS) (which reduces atrial effective refractory period 
[AERP]) permit more leading circles to coexist and promote AF, while interventions that 
increase WL, such as antiarrhythmic drugs that increase AERP, suppress AF by reducing 
the number of possible circuits24. Accordingly, most of antiarrhythmic drugs in use prevent 
the recurrence of AF by prolonging the WL22, 25, 26. 
However, AERP is not uniformly distributed in the atria and it has been 
demonstrated that higher heterogeneity of AERP promotes AF27. Shorter regional AERP 
and consequently shorter WL would need a circuit of small size for reentry to occur. As the 
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firing heart rate of reentrant tachycardia increases with decreasing circuit size, the smallest 
circuit size (or smallest WL) should control the overall atrial electrical activity24. Such 
notion would be compatible with single circuit reentry with a DF that is conducted with 
decreasing frequency to the remaining atrium. Thus, single circuit reentry or multiple 
circuit reentry could be the two faces of the same coin; that is, two expressions of the same 
mechanism that unfortunately we still try to understand. 
 
1.2.2 Spiral waves and rotors 
Experimental work in the last decades has sustained the theory of spiral wave 
activity as responsible for sustained reentrant activity in excitable systems such as the 
heart24, 28, 29. While in the leading circle model the electrical impulse excitation follows a 
circle with an unexcitable core (continuously excited by centripetal waves), according to 
the spiral wave theory the electrical impulse pursues a spiral trajectory continuously 
changing direction. There is a source sink relationship where the source represents the 
excited and depolarized tissue and the sink denotes the excitable tissue30, 31. If the source is 
too small it will extinguish itself in the vast sink; if it is too big it won’t find excitable tissue 
to continue its activity. The maintenance of the spiral wave requires an angle of curvature 
which is determined by tissue excitability and source-sink relationships. Low excitability 
(for example an increase in ERP or reduction in INa) or propagation strength (reduced CV) 
limit the curvature and enlarge the spirals with subsequent termination of AF24. Thus, 
inhibition of Na+ current should enlarge the spirals and terminate AF as Na-channel 
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blockers do. On the contrary, according to the leading circle they would have the opposite 
effect: the CV reduction would decrease the WL and would promote AF, which is not what 
has been observed clinically32, 33 and experimentally34, 35.  
Furthermore, experimental work demonstrated the existence of spiral waves during 
AF with optical36 and high density conventional mapping24, 37. A mathematical model of 
atrial activity with representations of atrial ionic and conduction properties in a 2-
dimensional grid indicated also a spiral wave activity during AF38. Moreover, recent studies 
of cholinergic AF in the isolated sheep heart demonstrated that high frequency sources in 
the PV region dominate and drive the fibrillatory activity throughout both atria39, 40. This 
and other experimental studies,17, 36, 40 has led to the hypothesis that “patients with AF have 
a focal or reentrant mechanism as the initiating cause of arrhythmia, while perpetuation of 
AF may depend on the uninterrupted periodic activity of a small number of discrete 
generators (rotors), most often localized in the LA and established by the interaction of 
propagating waves with anatomical heterogeneities in the atria”4, 39. The results of one of 
the first studies using rapid atrial pacing in dogs to promote AF support such a 
hypothesis41. Ablation of the area with the shortest cycle length (CL) during AF had a 
profound antiarrhythmic effect in that model. Clinical studies42-44 demonstrated that 
ablation in PV region and posterior wall, that is areas showing the fastest activity during 
AF as measured by CL in coronary sinus electrograms, prolonged at first the CL and 
subsequently terminated the arrhythmia. The areas of shortest CL would correspond to the 
generators (rotors) responsible for the maintenance of AF. Consequently, based on these 
  
11
 
works researchers focused recently their interest on the study of atrial electrical activity and 
its spectral properties during AF.  
 
1.2.3 Dominant Frequencies and AF 
The theorem of Fourier tells that any time series, such as a cardiac electrogram, can 
be represented exactly as the superposition of sinusoidal waves with different frequencies 
and amplitudes45. Consequently, an atrial electrogram can be decomposed in its spectral 
components creating a power spectrum where the sinusoidal wave of major amplitude 
shows a dominant peak (fig. 2). The frequency of that sinusoidal wave constitutes the 
dominant frequency (DF) and conceptually represents the inverse of the most frequent and 
dominant CL in the registration of an atrial electrogram (DF= 1 sec/CL sec). For example 
atrial flutter, which is an atrial arrhythmia with regular CL, has generally a DF of 5Hz that 
would be equal to 1 sec divided by the classical CL of 0.2 sec (300 beats per minute).  
 
Fig. 2  Example of atrial electrogram recording and its corresponding power spectra. The 
dominant frequency of 8.5 Hz corresponds to the frequency with the highest power.  
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Studies in isolated sheep hearts that have analyzed AF in frequency domains have 
provided evidence that AF has a high degree of spatiotemporal periodicity and high 
frequency rotors are responsible for maintaining AF17, 36, 40. Such rotors emanate generally 
from the PV region suggesting that these structures have an important role in maintaining 
AF45. Sanders et al46 creating DF maps from recordings of 120 points in both atria, 
correlated the DF distribution with ablation points and they found that ablation at PVs 
harboring high DF-sites resulted in an increase in CL of AF in either paroxysmal or 
permanent AF. However, arrhythmia termination during ablation occurred only in 88% of 
paroxysmal AF patients. In 87% arrhythmia termination was associated with ablation in 
high DF-sites.  
Moreover, there is substantial evidence from animal and human studies that during 
AF dominant frequencies are higher in LA than in the RA18, 19, 39, 47. According to studies in 
isolated sheep heart, most of the high frequency sources exist in the LA and at a critical 
frequency, a gradient develops between LA and RA. In a recent study, Atienza et al48 
demonstrated that elimination of LA to RA frequency gradients during ablation predicts 
long-term maintenance of sinus rhythm in AF patients. All these data clearly indicate that 
high-DF sites play a role in the maintenance of AF in a significant number of patients.  
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1.2.4 Complex fractionated atrial electrograms (CFAEs) and DF 
There is evidence that high DF areas likely represent either rotors or triggered 
activity that is driving AF17. In the clinical setting new electogram based measures of 
fractionation and rate have recently been proposed to guide AF ablation49. Several studies 
describe AF termination after ablation of sites with CFAEs49-51. CFAES were originally 
defined by Nademanee49 as either 1) electrograms with two or more deflections or 
continuous electrical activity over a 10 second period or 2) electrograms with a mean CL< 
120 msec over a 10 second recording period.  
Kalifa et al52 studying AF in isolated sheep hearts showed that the most fractionated 
activity was found in the periphery of high frequency sources, while a similar correlation 
between DF areas and fractionated electrograms was demonstrated by Everett et al53 in 
various animal models. Recently, Zlochiver et al54 presented a very interesting work, 
providing insights into the mechanisms underlying CFAEs. They showed that complex 
electrogram signals can be divided into strictly periodic components (presumably due to 
underlying rotors) and residual components deriving from meandering of spiral wave 
sources55. Registrations farther from rotors have weaker signals, that is more residual 
components coming from spiral wave meandering. Interestingly, a recent study correlated 
the sites of fragmented electrograms with those of ganglionated plexi of the autonomic 
nervous system56.  
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1.2.5 Autonomic nervous system and AF 
Autonomic nervous system plays a very important role in regulating heart rhythm. It 
is divided in two major portions: the craniosacral parasympathetic division and the 
thoracolumbar sympathetic division. Both divisions originate in nuclei within the central 
nervous system with preganglionic fibers that exit from the brain stem or spinal cord and 
terminate in ganglia57. 
Fig. 3  Distribution of parasympathetic and sympathetic fibers from central nervous system 
to ganglia and subsequently to peripheral organs. Sympathetic preganglionic fibers 
terminate in ganglia of the paravertebral chain, while parasympathetic preganglionic fibers 
terminate in peripheral ganglia in straight relationship with the organs and tissues 
innervated (adapted from Katzung57). 
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Sympathetic cardiac preganglionic fibers leave the central nervous system through 
thoracic nerves and terminate in ganglia located in the paravertebral chains (superior 
cervical ganglion, middle cervical ganglion, vertebral ganglion, cervicothoracic (stellate) 
ganglion)58-60. Parasympathetic cardiac preganglionic fibers leave the central nervous 
system through the vagal nerves and terminate on ganglion cells distributed diffusely in a 
complex system of ganglia located in fat pads or near the superficial vessels of the heart 
(fig. 3). In the same complex system of ganglia and fat pads terminate also the 
postganglionic sympathetic fibers constituting a plexus of cardiac nerves with multiple 
bifurcations and synapses among them. According to Chiou et al61 there are three fat pads 
around the heart that constitute the primary stations of the preganglionic parasympathetic 
fibers. Most efferent vagal fibers travel through a fat pad located between the SVC and 
aortic root and then project to the right pulmonary vein (RPV) fat pad (adjacent to the right 
pulmonary vein-atrial junction), or the inferior vena cava (IVC) fat pad (at the junction of 
inferior vena cava and left atrium). Notably the RPV fat pad would innervate the sinus 
node, while the IVC pad would innervate the AV node. However, a few vagal fibers bypass 
the SVC fat pad and go directly to either of the other two pads. The vagal postganglionic 
neurons to the sinus node are located in the RPV fat pad (adjacent to the RPV-atrial 
junction), while the vagal postganglionic neurons innervating the AV node are located in 
the IVC fat pad (at the junction of IVC and LA). However, fibers coming from the fat pads 
terminate in a complex system of intrinsic cardiac neurons located in small ganglia 
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scattered mainly on the posterior surfaces of the atria and superior aspect of the ventricles, 
including AV groove and circumscribing most of the main heart vessels59, 62, 63 (fig. 4).  
 
Fig. 4  Schematic representation of anatomical distribution of ganglia of the autonomous 
intrinsic cardiac nervous system on the epicardial surface. Most of the ganglia are located 
in the posterior atrial surface and superior atrial and ventricular surface circumscribing 
main heart vessels. A: Superior view. B: Posterior view IVC= Inferior vena cava, LIPV= 
Left Inferior Pulmonary Vein, LSPV= Left Superior Pulmonary Vein, LV= Left Ventricle, 
Pa= Pulmonary Artery, RIPV= Right Inferior Pulmonary Vein, RSPV= Right Superior 
Pulmonary Vein, SVC= Superior Vena Cava (adapted from Armour et al62, 64 and Yuan et 
al64). 
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Although epicardial fat pads and ganglionated plexuses contain mainly vagal 
ganglia, some sympathetic nerve fibers and even sympathetic neurons exist inside this 
complex system65. Whereas, electrical stimulation of the fat pads elicits a predominantly 
vagal response, parasympathetic blockade by atropine reveals the sympathetic excitation. 
Consequently, RF ablation or surgical removal of fat pads damages both vagal and 
sympathetic innervation65.  
Vagus nerves exert a negative dromotropic and chronotropic effect on the sinus and 
AV nodes while sympathetic stimulation has a positive effect. Right VS primarily slows 
heart rate while right stellate ganglion stimulation increases heart rate. Conversely, left 
vagal or left stellate stimulation exerts its negative or positive dromotropic effects mainly 
on AV conduction66. However, both sympathetic and parasympathetic systems act 
contemporaneously and the final effect depends on the interaction between them. Thus, VS 
produces a greater reduction in heart rate in the presence of tonic sympathetic stimulation 
(accentuated antagonism), while changes in AV conduction during concomitant 
sympathetic and VS are the algebraic sum of the changes occurring independently if we 
stimulate only each one of the branches of autonomic nervous system66. Furthermore, 
cardiac responses to brief vagal bursts begin after a short latency and dissipate quickly, 
while cardiac responses to sympathetic stimulation commence and dissipate rather slowly. 
So, VS influences beat to beat regulation, obtaining rapid responses to vagal influences, 
while sympathetic stimulation produces a slow temporal response. Such phenomena are 
manifested also in the measurement of heart rate variability in long electrocardiographic 
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recordings. In the power spectra of such recordings (obtained with Fast Fourier 
Trasformation as we saw in the DF section) the high frequency (HF) component 
corresponds to rapid modifications of heart frequency and would express the vagal 
influence on heart rate. On the contrary, the low frequency (LF) component would rather 
correspond to slow temporal heart rate modifications and would express the sympathetic 
influence on heart rate. 
Parasympathetic stimulation has long been recognized to play an important role in 
AF67. Coumel suggested that either limb of the autonomic nervous system, particularly the 
parasympathetic, can generate AF68. He distinguished a clinical form of vagal AF occurring 
generally in men without structural heart disease after meals or during rest (that is in 
situations of vagal preponderance). In contrast, adrenergic AF occurres generally in patients 
with heart disease, hyperthyroidism or pheocromocytoma, with arrhythmic episodes 
happening in daytime, during stress or exercise.  
Vagal AF promotion is related to a spatially heterogeneous reduction in AERP69. 
VS substantially reduces AERP and even if slightly increases CV70, shortens atrial WL 
promoting reentry and AF according to the leading circle model65, 71. The heterogeneous 
spatial distribution of ganglia containing vagal neurons and the corresponding 
inhomogeneous distribution of ACh in the atria could be responsible for ERP heterogeneity 
and consequent AF promotion. Sympathetic stimulation provokes a more homogeneous 
reduction in AERP still promoting AF, however not as much as VS71. 
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Due to the proarrhythmic potential of VS, it has been supposed that denervation of 
the atria would be beneficial in preventing AF. Chiou et al61 demonstrated that 
radiofrequency ablation of the three fat pads prevented the inducibility of sustained AF 
during bilateral VS. Autonomic denervation during AF ablation seems to play an important 
role for its efficacy72, while ablation of autonomic ganglia at the base of the PVs suppresses 
vagal responses in an experimental model of AF73. As recently suggested56, CFAEs may 
result from activation of the intrinsic cardiac autonomic nervous system and the clinical 
efficacy of ablation of CFAEs49 may result by a partial atrial denervation65.  
 
1.2.6 Atrial Remodeling 
In 1995, Allessie’s group published one of the most important works of the last 
decades74, demonstrating that AF changes the electrophysiological properties of the atria in 
a way to promote its persistence or even its repeated and early initiation after several 
terminations. “AF begets AF” representing a common clinical scenario in humans, where 
AF presents initially as paroxysms that become more and more persistent with time, 
progressing subsequently to chronic AF. The changes in electrophysiological, structural, 
contractile, neuroreceptorial or endothelial properties of the atrium created by the 
persistence of AF have been named as atrial remodeling75. Two major categories of atrial 
remodeling have been described: atrial tachycardia remodeling (ATR) occurring after rapid 
atrial tachyarrhythmias, and atrial structural remodeling (ASR) which is associated with HF 
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and other fibrosis promoting conditions76. ATR would decrease AERP and ASR would 
affect CV, both promoting AF according to the leading circle model.  
1.2.6.1 Atrial tachycardia remodeling (ATR) 
The alterations in ionic currents and properties of cellular excitability are termed 
electrical remodeling75. The most characteristic changes are ERP reduction and loss of ERP 
rate-dependence5, 74 (ERP doesn’t become shorter proportionally to the increase in heart 
rate). Moreover, spatially heterogeneous ERP changes and anisotropic conduction are 
important in establishing favorable conditions for reentry and subsequently persistence of 
AF4, 27, 75.  
ATR abbreviates atrial refractoriness by decreasing action potential duration (APD), 
primarily by ICaL downregulation and increased inward rectifier K+ currents76. ICaL is a 
calcium current passing through the L-type (long-lasting) calcium channels occurring in the 
later phases of calcium channel opening77. AF increases atrial rate ~10 fold, which 
increases atrial myocyte Ca2+ loading78. Therefore, atrial myocytes put forward different 
mechanisms in order to protect themselves from Ca2+. Yue et al79, studying an animal 
model of atrial tachycardia pacing to mimic AF, observed a progressive downregulation of 
the transient outward K+ current Ito and the L-type Ca2+ current ICaL, leading to APD 
shortening and impaired APD rate adaptation with consequent AF promotion. Subsequent 
work of the same group demonstrated transcriptional messenger RNA (mRNA) 
downregulation of the α-subunit of the L-type Ca2+ channel, as well as of the Kv4.3-Ito α-
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subunit as the causative mechanism80. Furthermore, Bosch et al obtained similar findings in 
human AF81.  
Intracellular Ca2+  loading by rapid atrial pacing leads to mitochondrial swelling and 
may jeopardize cell viability75. Declines in Ca2+ gradients between the cell compartments 
decreases atrial myocyte contractility and underlies the atrial contractile dysfunction 
observed in clinical AF75, 78. Such alterations in intracellular Ca2+ handling and cellular 
contractility have been named contractile remodeling75, 82.  
The voltage gated transient outward K+ current Ito is consistently decreased in 
ATR83. Its role in promoting AF is not well established. Ito opposes the inward Na+ current 
in the first phase of action potential. Therefore, a decrease of Ito may facilitate wave 
propagation by increasing action potential amplitude76. Decreases of Ito are associated with 
reductions in both mRNA and protein expression of its pore forming Kv4.3 subunit80.  
Moreover, substantial work in the last decade put in evidence the important role of 
the inward rectifier channel superfamily Kir in atrial cell repolarization and genesis of 
arrhythmia. Potassium channels of this family set the resting membrane potential of cardiac 
myocytes77. Kir passes an outward current when the membrane potential is above the 
potassium equilibrium potential and thus contributes on the late repolarization phase of the 
action potential, thereby regaining the resting membrane potential. Conversely, when cell 
membrane is hyperpolarized, Kir passes an inward current in order to maintain the high 
internal K+ activity and keep the resting membrane potential. The main background 
conductance that controls atrial resting membrane potential is IK1, a current passing through 
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Kir superfamily channels. AF increases expression levels of mRNA of Kir2.1 (channel 
subunit of Kir), consistent with larger IK176, 84. Moreover, an increase in IK1 has been 
observed in either human81, 85 or animal AF studies86, contributing to a faster repolarization, 
thus reducing further the APD75.  
Kir superfamily channels include also ligand-operated channels, of which the most 
noted is the muscarinic operated channel. The muscarinic K+ channel (mAChKir) is a 
heterotetramer of Kir3.1 and Kir3.4 (also known as GIRK1 and GIRK4)87. Stimulation of 
cardiac M2 muscarinic receptors by cholinergic agonists activates IKACh (acetylcholine-
regulated potassium current) which strongly promotes AF83 by stabilizing atrial reentrant 
rotors38. This is consistent with the clinical forms of AF beginning under vagotonic 
conditions68.  
Although, other subtypes of muscarinic receptors have also been associated with 
different K+ currents, such currents seem to possess delayed-rectifier properties, 
distinguishing them from classical IKAch88, 89. A reduction of IKACh subunits (Kir3.1 and 3.4) 
mRNA and proteins in AF patients has been reported83, 90, 91, corresponding to a decreased 
current response to M2-receptor stimulation84, 85. Furthermore, Yeh et al92 report a decrease 
of both cholinergic receptor-coupled K+ currents and corresponding expression of channel 
proteins after 1 week rapid atrial pacing. This IKACh decrease would lead to an increase in 
APD and ERP with lower theoretical propensity to AF.  
Nevertheless, even if functional IKACh is reduced, an increase in a constitutively 
active form of this current has been described as an important contributor in maintaining 
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AF93, 94. It has been shown that the inward rectifier potassium current IK1 is higher in 
patients with chronic AF and is associated with smaller muscarinic receptor-mediated 
IKACh84. Additionally, patients with chronic AF exhibit an agonist independent constitutive 
IKACh (IKACh,c) activity that contributes to the enhanced basal inward rectifier current93. In 
animal models, a similar constitutively active IKACh,c current is upregulated and independent 
of the presence of the agonist (ACh)94, while its inhibition in vitro by tertiapin increases 
APD and suppresses atrial tachyarrhythmias95. Whereas ATR94, 95 or chronic AF84, 93 
decreases agonist stimulated IKACh, an agonist independent (“constitutive”) IKACh,c  activity 
is enhanced93-96. Increased IKACh,c  was supposed to be secondary to an increase in 
mAChKir channels that for unknown reasons were becoming independent of ACh binding. 
However, mRNA and protein expression of Kir3 subunits are unchanged in experimental 
ATR94, 96 whereas they are decreased in chronic AF76, 93. Consequently, the increased 
mAChKir channels hypothesis was rejected. Rather, recent studies proved that AF induced 
enhancement of IKACh,c is due to increased single channel open probability caused by 
slowed channel closure96, secondary to altered channel phosphorylation97, 98. 
1.2.6.1.1 Neuroreceptorial remodeling 
Long term rapid atrial pacing creates the above described electrical remodeling. One 
of the characteristics of such remodeling is an increased heterogeneity in atrial 
refractoriness. Analogous to studies in ventricular arrhythmias, it has been proposed that a 
potential mechanism of such spatial dispersion of refractoriness could be the heterogeneity 
of autonomic innervation99. Thus, heterogeneous atrial denervation with application of 
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phenol facilitated sustained AF in one study. Consequently, based on the idea that “AF 
begets AF” there have been studies evaluating the possibility of an autonomic remodeling 
in animal models of rapid atrial pacing. Jayachandran et al100 demonstrated that rapid rates 
of AF produce a heterogeneous increase in atrial sympathetic innervations, while Chang et 
al101 showed that there is a significant nerve sprouting and sympathetic hyperinnervation in 
a canine model of sustained AF. However, it remains unclear if such neural remodeling 
promotes sustained AF. Recently, Yeh et al92 demonstrated that atrial tachycardia induces 
downregulation of muscarinic receptors, adding further evidence in favor of a 
neuroreceptorial remodeling occurring after prolonged atrial tachycardia. 
1.2.6.2 Atrial structural remodeling (ASR) 
Clinical AF has been associated with atrial fibrosis.102 Changes that include 
increases in extracellular connective tissue composition, cellular size, glycogen 
accumulation, myolysis, mitochondrial changes, or chromatin redistribution have been 
termed structural remodeling103. Fibrosis is a hallmark of arrhythmogenic structural 
remodeling104-106. Fibrosis occurs generally as a reparative process substituting 
degenerating myocardium with connective tissue, which causes interstitial expansion.  
Atrial fibrosis occurs in a variety of clinical settings such as senescence, cardiac 
dysfunction, mitral valvular disease, and possibly myocardial ischemia104. In a dog-model 
of congestive HF caused by ventricular tachypacing for 2-5 weeks, promotion of interstitial 
fibrosis induced sustained AF105. Complete recovery from tachycardia-induced congestive 
HF after 4-5 weeks of pacing cessation has been demonstrated107, 108. However, structural 
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remodeling with increased interstitial fibrosis remains unmodified, creating a substrate that 
can support prolonged AF109. The likelihood of AF increases with increasing extent of 
fibrosis110. Furthermore, Hanna et al showed that ventricular tachypacing-induced 
congestive HF was associated with substantially more fibrosis in the LA than in the left 
ventricle111. Although, AERP remains unchanged or increased after ventricular 
tachypacing, prominent conduction abnormalities in association with increased fibrosis 
create a favorable substrate to reentry according to leading circle model, thus promoting 
AF105. Consequently, therapeutic approaches targeting the prevention of the fibrous atrial 
remodeling could have a very important role in fighting the disease. 
Several profibrotic factors have been described. TGFβ1 is an important profibrotic 
factor112. Targeted cardiac TGFβ1 overexpression produces prominent atrial fibrosis113, 
while TGFβ1 overexpressing mice show an enhanced susceptibility to AF114. Angiotensin 
II is another well-established profibrotic molecule. Transgenic mice with cardiac-restricted 
angiotensin converting enzyme overexpression show marked atrial dilation with focal 
fibrosis and AF76, 115. Recent evidence attributes significant roles also to Platelet Derived 
Growth Factor (PDGF) and Connective Tissue Growth Factor (CTGF)76. 
 
1.3 Animal Models 
Numerous clinical and experimental studies have been published in an effort to 
understand the complex pathophysiology of AF24, 116. Despite the undoubted progress in 
explaining causal factors and pathophysiological mechanisms leading to AF, many 
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unanswered questions remain4. Therefore, many animal models have been developed, 
assisting continuously in the progress of our knowledge and in the acquisition of new 
important information41, 74, 117, 118. Among them the “atrial tachycardia remodeling” (ATR) 
animal model and the “vagal stimulation” (VS) animal model are frequently used in order 
to evaluate new potential therapeutic methods. 
 
1.3.1 Atrial tachycardia remodeling (ATR) animal model 
Lone AF presents clinically as a paroxysmal form with auto limited episodes. 
However, by the recurrence and perseverance of new episodes, AF becomes initially 
persistent, requiring pharmacological or electrical cardioversions, and subsequently chronic 
or permanent. The longer AF persists the more difficult it becomes to maintain sinus 
rhythm119. Progression from paroxysmal AF to persistent and permanent AF is associated 
with structural and biochemical changes. As previously mentioned, the alterations in ionic 
currents and properties of cellular excitability are termed electrical remodeling75, 120. The 
changes in myocyte number, chamber size, extracellular connective tissue composition, 
fibroblast proliferation, glycogen accumulation, mitochondrial composition and chromatin 
distribution have been termed as structural remodeling75, 103, while the contractile 
dysfunction secondary to altered Ca+2 handling represents the contractile remodeling75, 82, 
121.  
Most of the above knowledge regarding atrial remodeling came from animal 
models. In 1995 Wijffels et al74 showed that AF causes electrophysiological changes of the 
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atrial myocardium which promote the maintenance of AF (AF begets AF). Pacemakers 
sustaining AF by right appendage pacing were implanted in goats. After a week of pacing-
induced AF there was a notable shortening of the AERP associated with a remarkable 
increase in AF duration and inducibility.  
Moreover, other experimental work demonstrated that the primary stimulus to 
remodeling in AF is atrial tachycardia41, 117. Atrial tachycardia reduces AERP in a spatially 
heterogeneous fashion, promoting AF by reducing WL and increasing its heterogeneity27. 
Such conditions favor multiple circuit reentry inducing and stabilizing AF4. 
Following atrial tachycardia, significant changes in ionic currents and channels 
occur. There is a progressive reduction of the transient outward potassium current Ito and 
the L-type Ca+2 current ICa,L, leading to a net shortening of APD and impairment of the 
APD rate adaptation75, 79. Furthermore, an increase in IK1 has been observed, contributing to 
a faster repolarization (this current would act in the late phase of repolarization), thus 
reducing further the APD75, 81, 85, 86.  
IKACh is the acetylcholine-regulated potassium current. As previously mentioned, it 
is an inwardly rectifying current generally influencing late repolarization and resting 
membrane voltage. Stimulation of cardiac M2 muscarinic receptors by cholinergic agonists 
activates IKACh which strongly promotes AF83. A reduction of IKACh subunits mRNA or 
proteins in AF patients has been reported83, 90. This would lead to an increase in APD and 
ERP with lower theoretical propensity to AF. Nevertheless, even if functional IKACh is 
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reduced, an increase in a constitutively active form of this current has been described as an 
important contributor in maintaining AF93, 94.  
The ATR model is one of the animal models used in the present study. In each 
animal of the ATR group, a pacing lead was inserted into the right ventricular (RV) apex 
and connected to a subcutaneously-implanted VVI-pacemaker. Radiofrequency ablation of 
the AV node was performed and the RV-pacemaker was programmed at 80 bpm. A pacing 
lead in the RA appendage (RAA) was connected to a subcutaneously-implanted pacemaker 
to pace the atria at 400 bpm for 1 week. After 1 week, an electrophysiologic study was 
done, retrieving all the necessary information for the study.  
Recapitulating, ATR animal model gave useful information and clarified many 
aspects of the complex AF pathophysiology. The similarity of the animal model with real 
human clinical conditions was ascertained by the similarities in electrophysiological and 
biochemical variations that occur after atrial tachycardia in the animal model or AF in 
humans. However, many aspects of the pathophysiology of AF have yet to be clarified, 
especially concerning the role of the autonomic nervous system in initiating or maintaining 
the arrhythmia. 
 
1.3.2 Vagal stimulation (VS) animal model 
The parasympathetic nervous system has long been recognized as an important 
factor in the onset and maintenance of AF67. A form of vagal AF, occurring after meals or 
during rest (thus in situations of vagal preponderance), has also been reported68. VS 
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provokes a spatially heterogeneous ERP abbreviation inducing and maintaining AF71. On 
the contrary, a similar ERP reduction provoked by sympathetic stimulation doesn’t promote 
AF as much, due to a more homogeneous distribution of ERP in the atria71. 
The VS model is the second animal model that we used in our study. AF is easily 
induced and maintained for the whole time that vagus nerves are stimulated in this animal 
model. Both cervical vagal trunks are isolated, doubly ligated and divided. Bipolar hook 
electrodes are inserted into each nerve parallel to vagal fibers for several centimeters and 
subsequently bilateral vagal-nerve stimulation is delivered by a stimulator71. VS provokes 
ACh liberation at the terminal nerve endings. Stimulation of muscarinic receptors by 
acetylcholine activates IKACh resulting in shorter APD and therefore decreased AERP. On 
the contrary, a small increase in CV is observed. However, the final result is a net decrease 
of the WL, creating optimal conditions for microreentry and AF.  
A direct relationship of the intensity of VS with the capability of inducing and 
maintaining AF has been reported69. This property promoted the application of VS in many 
animal models in order to obtain easily an AF episode and performed various experiments. 
Clinical AF often begins under vagotonic conditions. Nevertheless, it is unknown how 
comparable this artificial vagal AF could be with the clinical forms of AF. 
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2. Hypothesis 
Both VS and ATR AF are not associated with structural heart disease and 
consequently they would represent two forms of idiopathic paroxysmal AF. VS and ATR 
animal models have common electrophysiological and molecular mechanisms in promoting 
AF. With the VS model we study the influence of the parasympathetic system in creating 
temporary electrophysiological alterations promoting AF, while with the ATR model we 
study the effect of atrial tachycardia in inducing more persistent electrophysiological 
alterations, leading to the perseverance of AF (AF begets AF74).  
Vagal AF promotion is related to a spatially heterogeneous reduction in AERP and 
reduced AERP rate adaptation71. Similarly to the effects of VS, atrial tachycardia 
remodeling reduces the AERP, the AERP rate adaptation and the WL while increasing the 
AERP heterogeneity27, 41, 74, 105, 117. Nevertheless, the time course of AF promotion due to 
atrial tachycardia remodeling is slower than that of AERP changes, indicating the 
involvement of additional mechanisms24.  
Interestingly, the VS and ATR substrate share some common molecular 
mechanisms. Stimulation of cardiac M2 muscarinic cholinergic receptors with cholinergic 
agonists in the VS model elicits a large inward rectifier K+ current, IKAch, which strongly 
promotes AF38, 83. Similarly, constitutively activated inward rectifier K+ current IKAch,c is 
also upregulated in cardiomyocytes from AF patients93 and contributes to ATR-induced 
APD abbreviation and atrial-tachyarrhythmia promotion in canine atrium83, 95. However, 
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ATR results in reduction in L-type Ca+2 current ICa,L, which contributes significantly to 
APD reduction and, accordingly, AERP. Thus, the main difference between VS and ATR 
model would be the reduction in Ca+2 current ICa,L.  
Recently, Pandit et al122 demonstrated in a computer model that in two experimental 
situations with similar APD reduction, an increase in inward rectifier currents accelerates 
and stabilize rotors more than a reduction in Ca+2 current ICa,L. Even if the two situations 
produced the same APD reduction, they had a different response in rotor acceleration and 
stabilization and probably in AF promotion, if such conditions were applied clinically.  
Based on the above observations, we hypothesized that similar situations could be 
reproduced by the VS and ATR animal models. Thus, we wanted to compare the two 
experimentally induced paradigms of AF in conditions of similar AERP shortening, in an 
effort to clarify different pathophysiological aspects of AF. Should a similar AERP 
shortening produce the same electrophysiological properties and similar AF promotion? 
Are there any electrophysiological differences between the models that can be paralleled to 
different clinical forms of AF or that can justify a different AF promotion?  
In order to clarify such aspects, we followed a 1:1 matching of VS dogs with ATR 
dogs to ensure similar sex and weight distributions, and similar effects on mean AERP. We 
adjusted VS parameters in each VS dog according to the mean AERP recorded at 8 RA and 
left-atrial (LA) sites in the preceding ATR dog (basic cycle length, BCL, 300 ms). We 
obtained the same mean AERP in both models and we obtained epicardial maps of 
activation that permitted a detailed study of classical electrophysiological variables in 
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various anatomical areas. Moreover, DF analysis and its correlation with the 
electroanatomical properties of the two models gave interesting pathophysiological inputs.  
Overall, the purpose of this work was to study the similarities and differences in the 
electrophysiological mechanisms underlying AF promotion in VS and ATR animal models, 
search for possible mechanisms that could explain such results, and finally try to correlate 
these models with clinical AF.  
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 3.1 Abstract 
BACKGROUND  There are many similarities between atrial effects of atrial-
tachycardia remodeling (ATR) and vagal-nerve stimulation (VS): both promote atrial 
fibrillation (AF), reduce atrial effective refractory period (AERP) and AERP rate-
accommodation, enhance AERP-heterogeneity and increase inward-rectifier K+-current. 
OBJECTIVE  To compare the consequences of ATR and VS at similar levels of AERP 
abbreviation in dogs. 
METHODS  ATR-dogs (n=6) were subjected to 7-day atrial-tachypacing at 400 bpm, 
with radiofrequency-induced atrioventricular block and ventricular-demand pacing (80 
bpm) to control ventricular response.  VS was applied in 6 matched dogs with 
stimulation-parameters selected to produce similar mean AERP-values to ATR-dogs. 
RESULTS  ATR and VS produced similarly-short AERPs (79±12 and 80±12 ms 
respectively), AERP rate-adaptation loss and AERP heterogeneity increases.  Although 
both ATR and VS increased AF duration, VS was significantly more effective in AF-
promotion, with mean AF duration of 992±134 seconds, versus 440±240 seconds 
(P<0.05) under ATR.  The greater AF-promoting effect of VS was associated with 
greater mean dominant-frequency values during AF (11.7±1.8 versus 10.0±1.3 Hz ATR, 
P<0.05).  VS greatly enhanced the spatial dominant-frequency variability, increasing 
the coefficient of variation to 15.2±1.9 Hz, versus 8.9±1.5 Hz for ATR (P<0.05), 
primarily by increasing per-dog maximum dominant-frequency (15.4±0.6 Hz, versus 
12.5±0.6 for ATR, P<0.01). 
CONCLUSION  For matched AERP-values, VS promotes AF more strongly than 
ATR.  Despite similar AERP-changes, VS produces considerably greater increases in 
dominant-frequencies, particularly maximum values, consistent with previous 
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suggestions that inward-rectifier K+-current enhancement is particularly effective at 
accelerating and stabilizing spiral-wave rotors that maintain AF. 
 
KEYWORDS:  Atrial remodeling; Arrhythmia mechanisms; Reentry; Autonomic 
function; Biophysics; Electrophysiology 
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Abbreviation List 
AERP:  atrial effective refractory period 
AF:  atrial fibrillation 
ATR:  atrial-tachycardia remodeling 
BCL:  basic cycle length 
CTL:  control 
CV:  conduction velocity 
DF:  dominant frequency 
ERP:  effective refractory period 
LA:  left atrial 
LAA:  left-atrial appendage 
LBB:  left-atrial side of Bachmann’s Bundle 
LIW:  left-atrial inferior wall 
LPW:  left-atrial posterior wall 
RA:  right atrial 
RAA:  right-atrial appendage 
RBB:  right-atrial side of Bachmann’s Bundle 
RIW:  right-atrial inferior wall 
RPW:  right-atrial posterior wall 
RV:  right ventricular 
VS:  vagal stimulation 
WL:  wavelength 
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3.2 Introduction 
Numerous studies have addressed the complex pathophysiology of atrial fibrillation 
(AF).1  Animal models have been used for over 100 years and have provided extensive 
relevant information.2  The atrial-tachycardia remodeling (ATR) paradigm, by which 
rapid atrial activation promotes AF, has provided important insights into AF 
mechanisms.1-3  Vagotonic AF has also been widely used, particularly to study 
pharmacological control.2  
 There are many similarities in the atrial properties associated with vagal versus 
ATR-induced AF-promotion.  Both involve reduced atrial effective refractory period 
(AERP) and AERP rate-adaptation,3,4 and both manifest increased spatial AERP-
heterogeneity.5,6  Vagal effects on AERP and AF are due to enhancement of the 
acetylcholine-regulated K+-current IKACh,7 and a significant portion of the ATR-effect is 
due to enhanced constitutively-active IKACh (IKACh,c).8  These similarities in 
electrophysiological effects and ionic-current changes suggest common mechanisms of 
AF promotion.  We therefore designed the present study to compare directly ATR-
related and vagal AF at matched levels of AERP-shortening. 
 
3.2 Methods 
3.2.1 Animal models and experimental groups 
 Animal-handling procedures were approved by the local Animal Research 
Ethics Committee.  Twelve mongrel dogs were studied in two groups:  1) 6 vagal-
stimulation (VS) dogs; 2) 6 dogs subjected to 1-week ATR as previously described.8  
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ATR dogs were initially anesthetized with sodium pentobarbital (30 mg/kg IV, 
additional 4 mg/kg doses as needed).  A pacing lead was inserted into the right 
ventricular (RV) apex and connected to a subcutaneously-implanted VVI-pacemaker.  
Radiofrequency ablation of the atrioventricular node was performed and the RV-
pacemaker was programmed at 80 bpm.  A pacing lead in the right atrial (RA) 
appendage (RAA) was connected to a subcutaneously-implanted pacemaker to pace the 
atria at 400 bpm for 1 week.  
 
3.2.2 Experimental protocol 
On study days, dogs were anesthetized with morphine (2 mg/kg sc) and α-
chloralose (120 mg/kg iv, followed by 29.3 mg/kg/h), and ventilated mechanically.  
Body temperature was maintained at 37°C.  In the ATR group the RA-pacemaker was 
deactivated.  A median thoracotomy was performed and a pericardial cradle created.  
Four bipolar Teflon-coated stainless steel electrodes were inserted into the RAA and left 
atrial (LA) appendages (LAA) for recording and stimulation.  Five silicon plaques 
containing 240 bipolar electrodes were sewn over the atrial epicardial surface.9  A 
programmable stimulator was used to deliver 2-ms twice-threshold current pulses.  
Signals were filtered (10-900 Hz) and digitized (12-bit resolution, 2-kHz sampling).  In 
vagal dogs, a bipolar RV electrode and VVI-pacemaker were used to demand-pace the 
ventricles at 80 bpm. 
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3.2.2.1 Experimental design 
VS dogs were matched 1:1 with ATR dogs to ensure similar sex and weight 
distributions, and similar effects on mean AERP.  We first performed an open-chest 
electrophysiological study in each ATR dog, then matched the subsequent VS dog for 
sex and weight.  We adjusted vagal-stimulation parameters in each VS dog according to 
the mean AERP recorded at 8 RA and left-atrial (LA) sites in the preceding ATR dog 
(basic cycle length, BCL, 300 ms).  
3.2.2.2 Vagal stimulation 
Both cervical vagal trunks were isolated, doubly ligated and divided.  Bipolar 
hook electrodes (stainless steel, insulated with Teflon except for the distal 10-15 mm) 
were inserted into each nerve parallel to vagal fibers for several centimeters.5  Bilateral 
vagal-nerve stimulation (0.2-ms pulse-width) was delivered by a Grass SD-9F 
stimulator (Quincy, MA). Vagal stimulation voltage and frequency were selected to 
produce the target AERP (average values 3.9±0.7 V and 12.2±0.6 Hz). After vagal-
stimulation parameters were established based on AERP, vagal stimulation was applied 
for 30 seconds and the sinus-node slowing response to vagal stimulation was assessed 
over the last 15 seconds (average baseline sinus cycle-length 360±8.5 ms, cycle-length 
during vagal stimulation 792±105 ms). This response was verified periodically during 
each experiment and vagal-stimulation parameters readjusted if necessary to produce a 
constant bradycardic response.  
3.2.2.3 Electrophysiological study 
AERP was measured at multiple BCLs in the RAA and LAA and at a BCL of 
300 ms at 6 additional RA and LA sites: posterior wall (RPW, LPW), inferior wall 
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(RIW, LIW) and the Bachmann bundle (RBB, LBB).  AERP was determined with 10 
basic stimuli (S1) followed by a premature extrastimulus (S2) with 5-ms decrements.  
The longest S1-S2 failing to capture defined the AERP.  The mean of 3 AERP values at 
each BCL was used for analysis.  If AERP values differed by >10 ms, 2 additional 
AERP measurements were obtained and the mean of all determinations was taken to 
represent AERP.  AF was induced with atrial burst-pacing at 10 Hz and 4×threshold-
current.  To estimate mean AF duration in each dog, AF was induced 10 times.  AF≥20 
min was considered sustained and was cardioverted with a synchronized direct-current 
shock.  A 20-min rest period was then allowed before experimentation was resumed.  
After 2 cardioversions, no further AF inductions were performed. 
 
3.2.3 Conduction and AERP analysis 
Epicardial mapping was conducted with the Cardiomap system (Research Center, 
Sacre-Coeur Hospital and Biomedical Engineering Institute, École Polytechnique and 
Université de Montréal, Montreal, Quebec).  Activation data were analyzed off-line 
with computer-determined peak amplitude criteria for activation, and were reviewed 
manually.  Electrogram timing was compared with QRS complexes to exclude 
ventricular electrograms. 
Conduction velocity (CV) was determined by analyzing activation at four 
electrode sites in the direction of rapid propagation in the RAA, RPW, RBB, LBB and 
LAA.5,9,10  Distance from the proximal site was plotted against activation time and CV 
was determined by linear regression (r>0.99 required for analysis).  Because of variable 
conduction in the left inferior-posterior wall and right inferior wall, CV could not 
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always be measured accurately in LPW, LIW and RIW, which were therefore not 
included in the analysis.  Local wavelengths (WLs) were calculated as the product of 
local CV and local ERP.  CV and AERP heterogeneity were quantified by calculating 
coefficients of variation of 5 regional CV values (COVCV= SDCV/meanCV × 100%) and 
8 regional AERP values (COVAERP= SDAERP/meanAERP × 100%). 
To evaluate spatial conduction-inhomogeneities, phase maps were constructed, 
based on previously-described methods.10  In brief, activation-time differences between 
each electrode and its neighboring sites were normalized to interelectrode distances and 
maximum values at each site were taken to indicate local phase delays. A phase-delay 
histogram was then constructed and values corresponding to the 5th, 50th and 95th 
percentiles designated P5, P50 and P95 respectively. P50 represents the median phase-
delay and is an overall conduction index.  The P5-95 expresses the range of phase 
delays and the variation coefficient (P5-95/P50) is a conduction-heterogeneity index 
independent of CV. 
 
3.2.4 Atrial frequency-spectrum analysis 
Spectral characteristics of activation at each site during AF were studied as 
previously described.9,11,12  Periodogram estimation was performed on 4-second samples 
to analyze frequency content in the 0.5 to 80 Hz band.  The mean of each signal was 
first subtracted to remove the DC-part of the signal.  A split-cosine, bell-tapering 
window was applied, with 5% of data points being tapered.  An estimate of the signal 
spectrum was obtained by using a smoothed periodogram with a weighting parameter 
M.12  M was determined semiautomatically with an unbiased risk estimator method to 
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choose the tuning parameter M for the smoothed periodogram.  The dominant frequency 
(DF) at each recording-site was defined as the frequency of the highest peak of the 
smoothed periodogram.9  The variability in DFs was assessed in each dog based on the 
coefficient of variation (COVDF = SDDF/meanDF×100%). 
 
3.2.5 Statistical analysis 
All results are expressed as mean±SEM.  Statistical comparisons between ATR 
and vagal-stimulation means were performed by unpaired t-tests, except in cases of 
repeated-measures data (such as AERP at multiple BCLs and AERP, CV and WL in 
multiple atrial regions), in which 2-factor ANOVA (ATR versus vagal-stimulation as 
one factor and the repeated-measure index such as BCL or region) was applied.  All 
data satisfied statistical criteria for normal distribution (Kolmogrov-Smirnov test) 
except for AF durations, which were normally-distributed after log-transformation and 
were so analyzed.  To test for differences between coefficients of variation, we 
performed an F-test of the variance ratio according to Lewontin.13  A two-tailed P<0.05 
was considered statistically-significant.  The control (baseline) values before vagal 
stimulation are shown as reference values for vagal and ATR conditions, but are not 
compared statistically.   
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3.3 Results 
3.3.1 Electrophysiological variables and properties of atrial fibrillation 
Matching was effective:  there were 2 male and 4 female dogs in each group, the 
mean weight averaged 29.2±5.9 versus 26.9±7.6 kg (P=NS) for ATR and VS groups 
respectively, and mean AERP values at 8 sites (BCL of 300 ms) were 79±12 and 80±12 
ms respectively (P=NS), versus 117±12 ms under control conditions.  There were no 
differences between vagal-nerve stimulation and ATR in terms of AERP and AERP 
rate-adaptation over a wide range of BCLs (Figure 5A).  However, mean AF durations 
were significantly greater under vagal-stimulation than with ATR (Figure 5B).  In 
addition, sustained AF requiring cardioversion occurred under vagal-stimulation in 6 of 
6 dogs versus only 2 of 6 ATR dogs (P=0.06, Fisher exact test).  
Both vagal-stimulation and ATR were associated with slightly larger overall CVs 
(by about 10% compared to control), based on the average of all regional values (Figure 
6A), but there were no differences between vagal and ATR values. Similarly, 
wavelength (WL) was shorter in both groups than in control (Figure 6B), but there were 
no significant differences between ATR and vagal-stimulation values.  AERP 
heterogeneity was larger under both vagal-stimulation and ATR, with COVAERP of 
26.8±4.1% and 23.2±10.6% respectively, compared to 11.3±4.7% under control 
conditions (Figure 7A), but vagal-stimulation and ATR values were not significantly 
different.  No significant differences were observed between groups for COVCV (Figure 
7B).  Thus, in both VS and ATR groups, after achieving a similar AERP, we observed 
similar CV values, similar WLs, and similar AERP heterogeneity.  Nevertheless, AF 
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duration was significantly more enhanced under vagal-nerve stimulation than with 
ATR.  We therefore examined regional changes in atrial properties. 
 
3.3.2 Regional changes in electrophysiological properties 
A quantitative analysis of the regional electrophysiological effects of vagal-
stimulation and ATR is shown in Figure 8.  AERP was smaller under both vagal-
stimulation and ATR than for control over a wide range of atrial sites (Figure 8A), but 
there was no statistical significance for the factor vagal-stimulation versus ATR.  
Regional values for CV are shown in Figure 8B.  Regional CV values were not 
significantly different between ATR and vagal-stimulation conditions.  Similarly, for 
WL, ATR and vagal-stimulation values were not significantly different from each other.  
Overall, regional differences in conduction, refractoriness and WL failed to provide any 
explanation for the different effects of vagal-stimulation versus ATR on AF duration. 
 
3.3.3 Local conduction abnormalities 
In an attempt to understand the ATR versus vagal-stimulation differences in AF 
promotion, we performed an analysis of local conduction properties with the use of 
phase-delay histograms, which may reveal pathophysiologically-significant changes 
even in the absence of global conduction alterations.10  The P50, reflecting average 
interelectrode activation-time differences, was not significantly different between vagal-
stimulation and ATR (Figure 9A).  Similarly, no significant changes occurred in P5-95 
(Figure 9B).  The P5-95/P50 (heterogeneity index) was not significantly altered during 
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RAA pacing, but heterogeneity increased significantly with vagal-stimulation during 
LAA pacing (Figure 9C), suggesting a greater increase in local conduction 
heterogeneity under vagal conditions during activation by LA drivers.  
 
3.3.4 Dominant frequency analysis 
Previous work suggests that DF analysis may provide insights into mechanisms of AF 
maintenance, and that sites of maximum dominant frequency (DFmax) may constitute 
driver regions responsible for AF perpetuation.14,15  Consequently, to delineate 
differences that might account for differential AF sustainability between ATR and 
vagal-stimulation conditions, we performed DF analysis at all recording sites during AF 
under each condition.  Figures 10A, 10B and 10C show representative electrogram 
recordings, and corresponding panels D, E and F display the respective power spectra 
obtained after Fast Fourier Transformation.  In the examples shown, single dominant 
peaks are observed with DF values of 8.5, 12.6 and 9.6 Hz for control, vagal-stimulation 
and ATR conditions respectively.  
 To obtain an initial impression of DF patterns in each data set, we averaged the 
DF values at each electrode site for all dogs in each group.  Figure 11 shows the results 
as heat charts, with mean DF at each site under each condition as a color varying from 
blue (smallest DF values) to red (largest values).  During AF under control conditions, 
DF values are generally in shades of blue, corresponding to values between 8 and 10.4 
Hz.  Under vagal-stimulation, much greater variability is seen, with some regions 
showing values of the same order as control and others with much larger values, up to 
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14 Hz, greatly exceeding those in control.  The ATR distribution is more similar to 
control, but does show some increased values. 
 Figure 12 provides overall DF data.  Mean DF obtained from values at all 240 
electrodes in each dog was significantly greater under vagal-stimulation than in ATR 
(Figure 12A).  Similarly, the coefficient of variation of DFs (COVDF) was significantly 
greater under vagal-stimulation than for ATR (Figure 12B), indicating a greater 
heterogeneity in atrial DF values under vagal-stimulation.  The DFmax values 
associated with potential driver regions were significantly greater under vagal-
stimulation compared with ATR conditions (Figure 12C), which were similar to control.  
Minimum DF values in each dog showed no significant variations between conditions. 
 
3.4 Discussion 
In the present study we compared the atrial electrophysiological consequences of 
vagal nerve stimulation and ATR at comparable levels of AERP abbreviation.  Despite 
similar effects on absolute AERP, AERP distribution and AERP rate-dependence, as 
well as on conduction indexes, vagal-stimulation proved to be more effective than ATR 
in promoting AF maintenance.  
 
3.4.1 Atrial electrophysiological consequences of vagal-nerve 
stimulation and ATR 
The parasympathetic system has long been recognized to play an important role 
in AF promotion.16  Vagal activation decreases atrial cardiomyocyte action potential 
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duration and hyperpolarizes atrial action potentials by inducing an acetylcholine-
dependent K+-current, IKACh.7 Vagal IKACh activation is spatially-heterogeneous, owing 
to spatially-variable distributions of vagal nerve endings and cholinergic receptors, 
resulting in spatially-heterogeneous actions that are believed to be important in AF-
promotion.5,7,17  The classical notion of the mechanism of vagal AF has been multiple-
circuit reentry promoted by strong WL shortening, increasing the number of 
simultaneous functional atrial reentry circuits.1,18  More recent studies have emphasized 
the importance of cholinergically mediated acceleration of high-frequency rotor sources 
corresponding to DFmax regions, with fibrillatory activity due largely to wavefront-
breakup related to structural and functional properties.7,19,20  
 The electrophysiological substrate maintaining AF in ATR-tissue is complex 
and evolves over time.21  At 1 week of ATR, spatially heterogeneous AERP changes 
predominate.22  Reductions in L-type Ca2+-current (ICaL) play an important role, but 
increases in inward-rectifying K+-currents, including IK1 and IKACh,c are also 
significant.8,21  The electrophysiological consequences of ATR share many similarities 
with those of vagal nerve stimulation: shortened AERP, reduced AERP rate dependence 
and enhanced AERP variability.  These similarities were all observed in the present 
study (Figures 5 and 7).  This outcome is perhaps not surprising, given that both 
interventions enhance inwardly rectifying K+-currents: muscarinic receptor-activated 
IKACh in the case of vagal nerve stimulation; IK1 and IKACh,c in the case of ATR.  The 
main difference between vagal-stimulation effects and ATR is ICaL-downregulation, 
which plays a prominent role in ATR1,23 but is not produced by vagal-nerve stimulation. 
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3.4.2 Novel findings and potential underlying mechanisms 
To our knowledge, this is the first study to compare directly the 
electrophysiology of ATR-induced AF promotion with that of vagal-nerve stimulation 
under matched effective refractory period conditions.  The result was in some sense 
surprising: despite indistinguishable changes in many electrophysiological parameters, 
vagal nerve stimulation was significantly more effective in promoting AF-maintenance 
than was ATR.  However, the data regarding effects on DF values and distribution, in 
combination with recent work regarding the biophysics of AF maintenance,7,14,19,20,24 
shed considerable light on the potential basis for the discrepancy between ATR and 
vagal stimulation effects.  The stability and persistence of cholinergic AF is closely 
related to the dynamics of rapidly rotating spiral wave generators.7,14,19,20  Cholinergic 
activation enhances the rate of spiral wave rotation, reduces spiral tip meander and 
prevents termination by annihilation against competing sources or tissue boundaries.  
Similarly, the stability of reentry in ATR-remodeled atrial substrates depends on 
primary rotor dynamics.24  
 Pandit et al. studied the determinants of ATR effects on rotor dynamics in detail24 
with the use of a previously developed mathematical model of remodeled human atrial 
APs25 incorporated in a 2-dimensional sheet of atrial tissue.  They compared the 
previously developed model (in which action-potential abbreviation results primarily 
from ICaL reduction), which the authors called “CAF1”, with a revised model 
incorporating a 100%-increase in IK1 inward rectifier current (called “CAF2”), based on 
experimental data.  Although both CAF1 and CAF2 action potentials accelerated and 
stabilized atrial rotors, the effect was larger with CAF2.24  Because the CAF2 action 
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potential duration was shorter, the authors also compared CAF2 with modified CAF1 
action potentials having a greater decrease in ICaL, to achieve durations similar to CAF2.  
The modified CAF1 model accelerated and stabilized rotor activity relative to CAF1 
simulations, but not to the same extent as CAF2.  Based on further analyses, the authors 
concluded that for the same degree of action potential abbreviation, inward-rectifier K+-
current enhancement produces stronger rotor acceleration and stabilization than ICaL-
reduction, because in addition to abbreviating action potentials, IK1 enhancement also 
hyperpolarizes atrial cell membranes.  Membrane hyperpolarization removes voltage-
dependent Na+ current inactivation, increases the source Na+ current and permits faster 
and more stable rotor activity.  During vagal stimulation, AERP reduction is 
accomplished solely by inward-rectifier (IKACh) current enhancement, whereas in ATR, 
AERP is decreased by a combination of ICaL reduction and inward-rectifier (IK1 and 
IKACh) current enhancement.  
Thus, based on the study by Pandit et al24, one would expect a greater degree of 
rotor stabilization and acceleration in the vagal stimulation condition (in which AERP 
abbreviation results from inward-rectifier current enhancement alone) than in the ATR 
condition (in which AERP abbreviation results from a lesser degree of inward-rectifier 
current enhancement combined with ICaL reduction).  The relative changes in DF 
observed with vagal stimulation versus ATR support this reasoning.  DF-maps during 
AF showed more acceleration (Figure 11), and mean DF values were significantly 
greater (Figure 12A) under vagal stimulation than in ATR.  In addition, there was 
greater variability in DF under vagal stimulation, as evident in DF-maps and COVDF 
values (Figure 12B).  The DF variability enhancement was due to much larger DFmax 
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values under vagal stimulation, whereas minimum DF values were not affected 
(Figure 12C).  These observations are consistent with previous experimental 
observations concerning the importance of regional heterogeneity in vagal effects on 
AF, with spatially-heterogeneous vagal effects resulting in zones of strong vagal action 
adjacent to zones of minimal or no vagal effect.5  
The prominent changes in DFmax under vagal stimulation agree with previous 
experimental observations suggesting that DFmax regions represent driver rotors that 
maintain AF and determine its stability.14,19,20,26,27  Our findings are therefore consistent 
with the notion that rotor wave dynamics are key determinants of the stability of AF.28,29  
Similar to our results, Everett et al30 noted that infusion of the cholinergic agonist 
methacholine produced greater increases in DFs and DF spatiotemporal variability 
compared with several other AF models, including ventricular tachypacing-induced 
heart failure, atrial tachypacing, and acute mitral regurgitation. The DF distribution of 
vagally induced AF in our study is surprisingly similar to the distribution of ablation 
lesions performed by Nademanee et al31 targeting complex fractionated electrograms in 
paroxysmal AF patients.  Although we cannot exclude a fortuitous coincidence, the 
similarity suggests a potentially important participation of vagal mechanisms in 
paroxysmal AF, as previously suggested by other investigators.32  
 
3.5 Potential limitations 
The conventional mapping system that we used has several limitations.  The 
spatiotemporal  resolution is insufficient to reliably track individual rotors.  We sampled 
only the epicardial surface, and atrial tissue has a complex 3-dimensional structure that 
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can participate in AF maintenance.33  One advantage of our system is that it allows for 
the gathering of data in the in situ heart under physiological conditions, without 
potential distortion from tissue excision, perfusion with crystalloid non-blood 
containing solutions and potentially toxic dyes, ultraviolet light energy and 
electromechanical uncouplers that are needed for higher-resolution optical mapping.  
 We matched dogs on the basis of weight and sex.  However, because our dogs 
were random-source mongrels, we did not know their age or breed, introducing 
potential uncontrolled sources of intergroup variability. 
 We studied ATR after 7 days of atrial tachypacing. A longer period of 
tachypacing (6 weeks) produced larger changes in DF values and heterogeneity versus 
control in the work of Everett et al30 than those that we observed in the present study. 
The clinical counterpart of our models may therefore be a relatively short duration of 
AF (corresponding to weaker ATR) versus a situation of strong vagal tone. This 
consideration may also account for the lack of clear increase in DF with ATR, despite 
the fact that patients with persistent AF have higher DF values than patients with 
paroxysmal AF.34 However, our primary objective was to compare the 2 paradigms 
under matching intensities in terms of mean atrial effective refractory period conditions, 
which we did succeed in accomplishing.  
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3.8 Figure Legends 
Figure 5. A. Mean±SEM atrial effective refractory period (AERP) in the RA 
appendage as a function of BCL.  B. Mean±SEM AF duration.  * P<0.05 
ATR versus vagal-stimulation (vagal). 
Figure 6. Effects of vagal-stimulation (vagal) and ATR on electrophysiological 
indices A. Conduction velocity (CV).  B. Wavelength (WL). 
Figure 7.  A. Atrial effective refractory period (AERP) heterogeneity expressed as the 
coefficient of variation (COVAERP).  B. Conduction velocity (CV) 
heterogeneity expressed as the coefficient of variation (COVCV).  COV 
(SD/mean×100) was used as an index of variability.  
Figure 8. Effects of vagal-stimulation and ATR on electrophysiological indexes in 
different areas of left and right atrium.  A. AERP  B. CV  C. WL. 
LAA=Left-atrial appendage; LPW= left-atrial posterior wall; LIW= left-
atrial inferior wall; LBB= left-atrial side of Bachmann’s Bundle; RBB= 
right-atrial side of Bachmann’s Bundle; RPW= right-atrial posterior wall; 
RIW= right-atrial inferior wall; RAA= right-atrial appendage.  *P<0.05 for 
ATR versus vagal-stimulation (vagal). 
Figure 9. Results of phase-delay analysis during pacing from the left-atrial 
appendage (LAA) or right-atrial appendage (RAA) under control, vagal-
stimulation and ATR conditions at a BCL of 300 ms.  A. Median of local 
phase differences (P50), B. Absolute heterogeneity (P5-95), C. 
Heterogeneity Index (P5-95/P50). *P<0.05 for ATR versus vagal-
stimulation (vagal). 
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Figure 10. Examples of electrogram recordings and of corresponding power spectra 
obtained at a single electrode under each condition.  The dominant 
frequency (DF) corresponds to the frequency with the highest power.  
Larger DFs were consistently seen under vagal-stimulation compared to the 
other conditions studied. 
Figure 11. Spatial distribution of mean DFs under each condition at each of the 240 
bipolar electrode positions, based on mean values at each point for all dogs 
studied.  Missing data points correspond to sites at which values were 
available for fewer than 3 dogs under the condition shown.  A. Atrial 
electrode-locations are shown for each set of electrodes.  B, C, and D. 
Mean DFs at each electrode-site are represented by a color scale (right) for 
each condition.  LA=Left-atrial appendage; LPW= left-atrial posterior wall; 
LIW= left-atrial inferior wall; LBB= left-atrial side of Bachmann’s Bundle; 
RBB= right-atrial side of Bachmann’s Bundle; RPW= right-atrial posterior 
wall; RIW= right-atrial inferior wall; RA= right-atrial appendage. 
Figure 12. Overall results of dominant-frequency (DF) analysis.  Comparison between 
groups of:  A. Mean±SEM DFs for each animal, obtained by averaging all 
DFs in each animal and then calculating mean±SEM for each condition.  B. 
Mean±SEM of coefficient of variation (COVDF) of DFs for all electrode-
sites in each animal.  C. Mean±SEM maximum (max) and minimum (min) 
DF values in each animal under each condition. *P<0.05, **P<0.01 for 
ATR versus vagal-stimulation. 
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 4. Discussion 
In the present study we compared the VS and ATR AF substrates having as a 
presupposition a similar atrial ERP. Despite observing similar CV and WL, we showed 
that VS AF is faster and more persistent comparing to ATR AF. This occurred 
independent of changes in the classical electrophysiological variables, which have been 
considered to date as the main contributors in the electrophysiological remodeling 
following AF74. VS dogs however presented a heterogeneous distribution of higher DF 
as well as a higher heterogeneity in local conduction. These results suggest that the 
heterogeneous anatomical distribution of vagal ganglia and the VS-induced cellular 
hyperpolarization are important contributors to AF-maintaining rotor stabilization and 
acceleration. Thus, the similarity of the substrates is only superficial, indicating 
analogous differences in respective clinical forms or phases of AF. 
 
4.1 Electrophysiological properties of VS and ATR substrate 
The parasympathetic system has long been recognized to play an important role 
in AF promotion67. Vagal AF is related to a spatially heterogeneous reduction in atrial 
ERP producing a substrate that is very propitious for AF71. AF has been induced in 
different experimental models with either infusion of ACh in the sinus node artery123 or 
by direct stimulation of the vagal cervical nerves. Similarly, atrial tachycardia 
remodeling reduces the atrial ERP, the ERP rate adaptation and the WL while 
increasing the ERP heterogeneity27, 41, 74, 105, 117.  
In our study, we obtained the same mean ERP reduction comparing to CTL in 
both models of AF (fig. 5A). The coefficient of variation (CoV) of ERP, used as an 
index of heterogeneity, was also higher in both AF groups (fig. 7A). Additionally, the 
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study of other basic electrophysiological variables didn’t highlight significant 
differences between VS and ATR dogs. 
In both groups, we obtained an increase in CV and a decrease in the WL of 
similar proportions, comparing always to CTL (fig. 6). Whereas a VS increase in CV is 
in accordance with previous studies70, 71, there is still controversy concerning the ATR 
effect on CV75. The varying results regarding CV changes in ATR substrate may point 
to the existence of multiple factors and changes that can affect CV. A decreased INa 
would tend to decrease CV124, while a decreased ERP or an increased connexin 
expression75, 125, 126 would have the opposite effect. 
Gaspo et al117, 124 showed a reduction in CV in ATR dogs. However, CV 
measurements were done in the RPW, where we also didn’t find significant differences 
in CV between CTL and ATR. Our results are in accordance with Fareh et al27 and 
Wijfells et al74, where pacing techniques similar to ours (from left and right atrial 
appendage) were used for the calculation. Furthermore, animal and human studies125, 126 
showed an increased connexin (Cx40) expression especially in the lateral cell 
membrane, potentially contributing to anisotropic impulse conduction, while other 
studies127, 128 found Cx40 significantly reduced in patients with persistent AF. 
Although we ascertained an increase in CV, there was a significant decrease of 
WL (WL=ERPxCV) in both AF groups (fig. 6B). The WL reduction could explain the 
inducibility of AF in VS and ATR, according to Allessie’s leading circle model4, 21, but 
it doesn’t justify the promotion of persistence of AF in VS compared to ATR. Overall, 
VS and ATR groups shared similar differences in all main electrophysiological 
variables, but had a different effect on the persistence of AF.  
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Nevertheless, the evaluation of local conduction abnormalities by phase delay 
analysis revealed important differences between the two AF substrates. Whereas, in 
ATR group, according to previous studies105, 129, phase delay analysis didn’t 
demonstrate significant differences with CTL, the heterogeneity index, measured in 
phase delay maps created under left auricular pacing, was significantly higher in the VS 
group compared with ATR (fig. 9C). A similarly higher heterogeneity index in the VS 
group, though not significantly (p=0.06), was also observed during right auricular 
pacing. Therefore, the enhanced anisotropic conduction and subsequent heterogeneity of 
repolarization in the VS group would establish more favorable conditions for reentry 
and justify the observed promotion of permanent AF4, 75. 
Of particular interest is also the observation, that the difference in conduction 
heterogeneity seems more important when measured during left auricular pacing 
(heterogeneity index of VS vs ATR during left auricular pacing p<0.05, while during 
right auricular pacing p=0.06). Wang et al69 showed that the ability of atrial extrastimuli 
to induce AF varied with the stimulation site, while Lammers et al130 found that 
premature extrasystoles enhance heterogeneity of conduction which leads to leading 
circle reentry. In 1998 Haissaguerre et al demonstrated that the pulmonary vein muscle 
sleeves are the most frequent source of ectopic beats which initiate AF14. Furthermore, 
in a recent study based on previously developed mathematical and anatomical 
models131, 132, Gong et al suggested that the atria are more vulnerable to premature beats 
originating in the pulmonary veins (PV) than the RA133. These authors studied the 
window of vulnerability, or range of intervals, in which ectopic beats from different 
anatomical points can induce AF. They found that for ectopic foci in the RA, especially 
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those closer to the sinoatrial node, such as the superior vena cava and crista terminalis, 
the size of the window of vulnerability for the induction of AF was markedly smaller 
than that of the PV ectopic foci. Accordingly, our results of conduction heterogeneity 
were congruent with the previous study. Thus, the increased heterogeneity in 
conduction, which was found predominantly during left pacing in VS dogs (fig. 9C), 
could be the expression of a higher vulnerability of the VS substrate in left atrial ectopic 
beats. However, induction of AF in our study was performed only with right atrial 
pacing and, therefore we don’t have data of vulnerability differences between left and 
right atrium, which could further support or refute this hypothesis. 
 
4.2 Leading circle model, spiral wave theory and our study 
Over the past 50 years, multiple circuit reentry has been the dominant 
pathophysiological theory of AF4. Moe and coworkers20 developed the multiple wavelet 
reentry theory according to which AF is characterized by a large number of propagating 
wave fronts. However a sufficient number of these wave fronts must always find 
excitable tissue in order for the arrhythmia to persist.  
Based on these concepts and in subsequent experimental work Allessie and 
colleagues21, 22 developed the “leading circle” model of functional reentry. The WL is 
the distance travelled by the electrical impulse during the time of ERP and equals the 
product of the ERP with the CV. If the dimensions of the tissue involved are shorter 
than the WL, the presuppositions of reentry are missing, as the electrical impulse 
encounters unexcitable tissue and consequently extinguishes. Accordingly, most 
antiarrhythmic drugs in use prevent the recurrence of AF by prolonging the WL22, 25, 26.  
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However, experimental work in the last decades has sustained the theory of 
spiral wave activity as responsible for sustained reentrant activity in excitable systems 
such as the heart24, 28, 29. While in the leading circle model the electrical impulse 
excitation follows a circle with an unexcitable core (continuously excited by centripetal 
waves), according to the spiral wave theory the electrical impulse pursues a spiral 
trajectory continuously changing direction. There is a source sink relationship where the 
source represents the excited and depolarized tissue and the sink denotes the excitable 
tissue30, 31. If the source is too small it will extinguish itself in the vast sink; if it is too 
big it won’t find excitable tissue to continue its activity. The maintenance of the spiral 
wave requires an angle of curvature which is determined by tissue excitability and 
source-sink relationships. Low excitability (for example an increase in ERP or reduction 
in INa) or propagation strength (reduced CV) limit the curvature and enlarge the spirals 
with subsequent termination of AF24. Thus, inhibition of Na current should enlarge the 
spirals and terminate AF as Na-channels blockers do. On the contrary, according to the 
leading circle they would have the opposite effect: the CV reduction would decrease the 
WL and would promote AF, which is not what has been observed clinically32, 33 and 
experimentally34, 35. Comtois et al31 have recently studied in a mathematical and 
experimental model the mechanism by which INa blockade terminates vagal AF. 
Arrhythmia termination was related to decreased source Na+-current in the face of large 
IKACh-related sinks (source-sink relationship), leading to destabilization of primary-
generator rotors and their subsequent annihilation. This was indirectly expressed also by 
the reduction in maximum DF values observed in AF after Na-channel blockade. 
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The previous results are in agreement with the results of our study. Both VS and 
ATR AF substrate presented similar electrophysiologic modifications. ERP reduction 
was artificially equal in both substrates. Despite the fact that CV was similarly increased 
and WL was similarly reduced in both substrates, we found significant differences in 
AF properties. AF duration was significantly longer and DFs and conduction 
heterogeneity were significantly higher in VS dogs. Such phenomena couldn’t be 
explained by the leading circle model as the WL was similar in both substrates. 
On the contrary, the increase in IKACh related to VS would hyperpolarize the 
diastolic membrane potential, leading to a reduction of the duration of action potential, 
as well as a faster recovery and subsequent increased availability of Na+ channels. 
According to experimental animal and computer models122, 134, such an increase in 
inward rectifier K+ current would lead to an increase in rotor frequency and a propensity 
to stabilization of rotors resulting in AF promotion. The analogies with our VS model 
are obvious. Furthermore, the higher DFs in VS dogs is another indirect index of the 
rotor frequency increase, testifying to the aptness of the spiral wave reentry theory in 
our model. 
 
4.3 Role of autonomic ganglia, spiral waves and rotors 
DF analysis demonstrated higher values in the VS group comparing to ATR 
group (fig. 12A). DF heterogeneity, expressed as a coefficient of variation, was also 
higher in VS group (12B). Consequently, there was a clear association in our study 
between higher and heterogeneously distributed DF values and increased duration of AF 
in the VS group. Our results are similar to previous work where AFCL was examined71, 
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117. Moreover, recent studies showed high DF values after electric or ACh induced 
stimulation of cardiac autonomic ganglia38, 53, 73, 134, 135. However, to our knowledge this 
is the first study comparing the spectral properties of VS AF with ATR AF. 
In their classical work Wijffels et al74 remarked that AF was self-terminating 
when CL >120msec, while an exponential increase in the AF duration was observed for 
AF CL <120msec (equivalent a 8.3Hz). According to emerging experimental 
evidence17, 36, perpetuation of AF may depend on the uninterrupted activity of a small 
number of discrete generators (rotors), established by the interaction of propagating 
waves with anatomical heterogeneities in the atria39. As few as 1 rapidly discharging 
rotor may be sufficient to maintain fibrillatory activity during cholinergic AF17, 36, 38, 136. 
Our results are congruent with the above notions. Rapidly firing drivers and higher DF 
promote AF maintenance in the VS group in comparison with ATR. 
Stimulation of cardiac M2 muscarinic cholinergic receptors by cholinergic 
agonists elicits a large inward rectifier K+ current, IKACh, which strongly promotes AF38, 
83. In a mouse knockout model lack of IKACh prevented AF137. On the contrary, as we 
discussed in the paper, according to experimental animal and computer models, an 
increase in an inward rectifying K+ current, such as IK1 or IKACh tend to increase rotor 
frequency and stabilization122, 134. The increase in an inward rectifier K+ current 
hyperpolarizes the diastolic membrane voltage, resulting in the observed reduction of 
the duration of action potential, as well as a faster recovery and subsequent increased 
availability of Na+ channels. The final result would be the acceleration and stabilization 
of rotors, promoting the permanence of AF. 
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Fig. 13. Anatomical distribution of ganglia of the autonomous intrinsic cardiac nervous 
system A: superior view B: posterior view (adapted from Armour et al62).Analogous 
distribution of C: DFs in VS induced AF and D: ablation lesions following CFAEs 
(Nademanee et al49.) 
 4.4 Clinical implications 
Previous studies showed a left to right gradient in DF in patients with 
paroxysmal AF but not persistent AF18, 19, 39, 47. It has been found that higher DFs with 
lower spatiotemporal periodicity are present in patients with persistent AF46, 47. In 
analogy, we observed higher DFs and permanent AF only in the VS group. 
Accordingly, we found a similar tendency in left to right DFs gradient in the ATR group 
(after 1 week pacing) which is comparable with the paroxysmal AF groups in human 
studies. Ablation of PVs results in a loss in the left-to-right DF gradient in patients with 
paroxysmal AF and in fewer AF episodes47. However, in an animal model, AF 
promotion by VS was not influenced by the presence or absence of PVs73. 
Consequently, parasympathetic activation seems of primordial importance in prolonging 
AF, suggesting a possible role even in the persistent clinical forms of AF.  
The distribution of DFs in VS induced AF (fig. 13C) in our study is surprisingly 
analogous to the distribution of the ablation lesions performed by Nademanee et al49, 
following the allocation of complex fractionated electrograms (CFAE) (fig. 13D), in 
patients with paroxysmal or persistent AF. Such distribution is also analogous to the 
distribution of vagal ganglia according to Armour et al62 (fig. 13A and B). Kalifa et al52 
studying AF in isolated sheep hearts showed that the most fractionated activity was 
found in the periphery of high frequency sources, while a similar correlation between 
DF areas and fractionated electrograms was demonstrated by Everett et al53 in various 
animal models. As recently suggested56, CFAEs may result from activation of the 
intrinsic cardiac autonomic nervous system and the clinical efficacy of ablation of 
CFAEs49 may result by a partial atrial denervation65. Thus, as our results suggest, ACh 
release from epicardial ganglia after vagal stimulation would accelerate and stabilize 
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different rotors maintaining AF. Therefore, DFs would correspond to the regions of 
vagal ganglia, which are also the regions of CFAEs.  
Our results reinforce the idea of ablation of vagal ganglia in order to reduce 
duration and number of AF episodes138. However, the importance and the timing of 
such ablation (simultaneously with PV ablation to prevent recurrences and remodeling, 
or in a second procedure) have still to be defined. Furthermore, studying the vagal 
effects after different periods of ATR would probably clarify significant aspects of the 
pathophysiological modifications that occur in the passage between paroxysmal and 
permanent AF and could suggest interesting possible therapeutic solutions. 
 
4.5 Potential limitations 
The same animal group (6 dogs) was used for the electrophysiologic evaluation 
in baseline conditions and under VS. This resulted in fewer animals sacrificed, but, on 
the other hand, it could have affected partially our results under VS. The elapsed time 
between the start of the operation and the actual VS was considerable due to the 
electrophysiologic measurements in baseline conditions. This could have influenced the 
autonomic tone of the animals. Nevertheless, our results were similar to previous 
studies69, 71 where 2 separate groups of animals were used.  
Electrophysiological variables were measured at a CL of 300msec. CV was 
measured in left and right atrial areas after pacing from the LAA or RAA respectively. 
This method permitted the measurement in lines of electrodes vertical to isochronal 
lines. However, RIW, LPW, and LIW CV couldn’t be measured accurately in every 
dog, because of variable conduction in these areas, and therefore they were excluded 
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from the analysis. Consequently, mean CV and WL were similar in VS and ATR group 
for the analyzed areas, but we cannot exclude that differences could exist in the 3 not-
analyzed areas.  
Moreover, our mapping system samples quite extensively the epicardial atrial 
surfaces, but does not provide information about septal activation or the activation of 
subendocardial structures. Therefore, our results regarding the anatomical distribution 
of DFs are valid for the epicardial surface, but not for the respective endocardial 
surface, where ablation techniques are mostly applied. However, the similarity of our 
results in ATR group (left DF predominance) with clinical studies using endocardial 
mapping18, 46, 47, as well as the analogy of VS DFs distribution with CFAE distribution 
in human and animal studies19, 49, 52, 134 support the validity of our results even for the 
endocardium. 
 
4.6 IKACh , IKACh,c , muscarinic receptors, DF and future 
research 
Human AF leads to an increase in IK181 and similar changes have also been 
observed in animal studies95. Consequently, we would expect an increase in DF even in 
the ATR model that however we didn’t detect. A possible explanation would have its 
scientific base in autonomic nervous remodeling based mainly in dissimilar anatomic 
distribution of autonomic ganglia and receptors between left and right atria, as well as 
diverse receptor downregulation. 
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Kir3.1 and Kir 3.4 are channel subunits that form the acetylcholine regulated 
channel IKAch. Decreases in both mRNA84 and protein90 of these subunits have been 
reported in human and animal AF, corresponding to a decreased current response to M2 
receptor stimulation83, 84. Furthermore, all three muscarinic receptor subtypes (M2, M3, 
M4) which are coupled to K+ currents in atrial cells from LA and PV undergo an ATR 
downregulation process92. However, contradiction exists about the distribution of 
muscarinic receptors in the different atrial regions139, 140 and the proportion of 
downregulation in each atrial area is unknown. Our results (fig. 11 and fig. 13) indicate 
that the distribution of mean DFs in the VS group follows almost precisely the anatomic 
allocation of atrial ganglia, as previously described by Armour et al62, 64. In ATR dogs, 
the driver zones showed variable location and their distribution was less clear.  
 
Fig. 14 Mean±SEM DFs for left atrium and right atrium for each animal, obtained by 
averaging all DFs in each animal and then calculating mean±SEM for each condition. 
 
79 
 
 
Although the LAA is almost deficient in ganglia, we noticed somewhat higher 
values in DF in ATR dogs. A comparison of mean DFs in left and right atrium showed a 
tendency toward higher DFs in left atrium (p=0.07 not significant), while there wasn’t 
such tendency in the analogous comparison in VS or CTL group (fig. 14). According to 
these results, we formulated the hypothesis that, in the ATR group, the downregulation 
of the muscarinic receptors would be higher in the anatomical areas overlapped by 
neural ganglia. AF would promote parasympathetic activation as an autonomic nervous 
reaction to higher atrial and/or ventricular frequencies. Consequently, as a result of the 
activation of IKACh, an internalization of muscarinic receptors would follow with 
subsequent desensitization of this K+ current141. Downregulation of the receptors would 
probably be higher in the place where higher amounts of Ach were liberated such as 
regions underlying the neural ganglia. An index of this regionally specific 
downregulation would be the different distribution of DFs in our experiment: various 
and heterogeneous, following ganglia distribution in VS group (fig. 11C); more 
homogeneous in frequency values but with a left predominance in ATR group (fig. 
11D). Physiologically, this would correspond to a homeostatic response of the organism 
in the face of neural heterogeneity which as a conseguence reduces the sustainability of 
AF. Evidence of that is the shorter duration of AF in ATR group in comparison to VS.  
Further support comes from studies which suggest that in ATR, in concert with a 
reduction in an ACh stimulated IKACh, there is an increase in a constitutively active form 
of this current (IKACh,c)75, 93-95. IKACh channels can be constitutively active in the absence 
of cholinergic agonist stimulation83, 93-95. There is evidence that IKAch and Kir3 channels 
(KACh) may be greater in the left than the right atrium134. Accordingly, VS and ACh 
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infusion would create higher driver rotors in the richer in IKACh channels left atrium. 
However, we noticed the opposite effect; no difference in DF was observed between left 
and right DFs (fig. 14), while mean DFs in the RA appendage tended to be higher than 
LA appendage in VS group (p=0.06). In order to interpret these results, we should 
consider the notion that the muscarinic receptor and KACh channels are two separate 
entities, with a G protein playing the role of intermediary142. Thus, vagal nervous 
stimulation would result probably in higher local concentrations of ACh in discrete 
atrial regions containing muscarinic receptors with variable effect and different 
anatomical distribution. Therefore, VS would be highly arrhythmogenic, because of the 
anatomical imbalance in the distribution of neural ganglia, while downregulation of the 
muscarinic receptors with respective channels could be partly beneficial. However, the 
existing anatomical imbalance in KACh channels would still be proarrhythmic because of 
the constitutive IKH current83. Moreover, the inhibition of such current with tertiapin has 
been proved beneficial in the suppression of sustained tachyarrhythmias in ATR 
animals95. 
On the other hand, rapid right atrial pacing produces a heterogeneous increase in 
atrial sympathetic innervation, with preeminent effects in right atrium100. Additionally, 
Chang et al101 in a canine model of sustained AF showed that there is a significant nerve 
sprouting and sympathetic hyperinnervation that is higher in the right atrium compared 
to left atrium. Consequently, we cannot exclude that right atrial pacing could have 
caused significant ACh discharge from neural elements in the vicinity of the stimulation 
site, thus promoting downregulation of muscarinic receptors and channels with parallel 
sympathetic nerve sprouting mostly in RA. Nevertheless, the above studies showed 
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significant nerve sprouting and sympathetic hyperinnervation even in LA, while in 
control dogs it seemed that the RA also tended to have a higher nerve density than the 
LA and septum. Furthermore, there was no correlation between the duration of pacing 
and the density of cardiac nerves in either RA or LA.  
In conclusion,, we need more information to prove our hypothesis. While 
numerous studies19, 39, 47 demonstrated a left to right gradient in DF in accordance with 
the same tendency presented in ATR in our study, there isn’t any work to our 
knowledge which studied the effect of direct VS in ATR conditions. Such a study would 
help us clarify the importance of parasympathetic stimulation in persistent or chronic 
AF. Moreover, comparing regional densities of muscarinic receptors and IKACh currents 
after either right or left atrial pacing could clarify important aspects of a supposed 
neuroreceptorial remodeling.  
 5. Conclusion 
For a comparable AERP, VS AF is faster and more persistent than AF with an ATR 
substrate. These results are consistent with modeling work suggesting that VS-induced 
hyperpolarization is an important contributor to AF-maintaining rotor stabilization and 
acceleration. Important differences in local conduction and higher heterogeneity in VS AF 
contribute also significantly in the different pathophysiological manifestations of the two 
substrates. In addition, our study adds further evidence that spiral wave theory probably 
interprets better the complex AF phenomena compared to leading circle concept. According 
to the latter, for similar AERP and WL we shouldn’t find any differences in AF promotion.  
Furthermore, during VS, the spatial distribution of high DFs during AF follows 
strictly the anatomic distribution of epicardial ganglia and shows high heterogeneity. An 
interesting correlation of CFAEs with DFs and consequently vagal ganglia was also 
suggested by the electroanatomical mapping performed in our study. Therefore, based also 
on previous observations72, 73, 138, 143, ablation of vagal ganglia during AF ablation could 
also be advantageous. 
A higher heterogeneity in VS DFs was also noted, while in the ATR model there 
was a tendency to higher DFs in the LA, in accordance with previous animal and human 
studies18, 19, 39. We hypothesized a continuous vagal activation in the ATR model as a 
response of the autonomic nervous system to the high heart rate used to produce the model 
of electrical remodeling. A major downregulation of muscarinic receptors in the areas of 
vagal ganglia would follow, which would unmask the acetylcholine independent 
constitutive activity of IKACh channels. As long as these channels are more numerous in the 
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LA, rotors would have higher frequencies in the LA and consequently DFs would be higher 
in the LA as observed in our experimental study. Since AF duration is shorter in ATR, such 
downregulation of receptors seems beneficial. However, further studies are needed to 
confirm or reject such a hypothesis. In particular, the study of VS in ATR models of 
different pacing duration would help us clarify various aspects of the neuroreceptorial 
remodeling and could probably give insights to the pathophysiological passage from 
paroxysmal AF to more persistent forms. Moreover, the comparison of the 
electrophysiological and neuroreceptorial effects of left atrial with right atrial pacing could 
also contribute substantially in the same direction.  
Overall, even if VS and ATR AF share many common features, there are important 
pathophysiological differences, which may correspond to different forms or phases of 
clinical AF and would need therefore different therapeutic strategies. The role of 
parasympathetic stimulation in different phases of electrical or structural atrial remodeling 
merits further consideration in future studies. 
  
 
Bibliography 
1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the 
Management of Patients with Atrial Fibrillation: a report of the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines and the 
European Society of Cardiology Committee for Practice Guidelines (Writing Committee to 
Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): 
developed in collaboration with the European Heart Rhythm Association and the Heart 
Rhythm Society. Circulation 2006;114:e257-354. 
2. Brugada R, Kääb S. Genetics of Atrial Fibrillation: The Clinician's Perspective. In: 
Natale A, J J, eds. Atrial Fibrillation From bench to bedside. Totowa: Humana Press; 
2008:69-76. 
3. Olgin JE, Zipes DP. Specific Arrhythmias: Diagnosis and Treatment. In: Zipes DP, 
LIbby P, Bonow RO, Braunwald E, eds. BRAUNWALD'S HEART DISEASE: A 
Textbook of Cardiovascular Medicine. 7th ed. Philadelphia: Elsevier Saunders; 2005:803-
63. 
4. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-26. 
5. Nattel S, Ehrlich J. Atrial Fibrillation. In: Zipes DP, Jalife J, eds. Cardiac 
Electrophysiology: From cell to bedside. 4th ed. Philadelphia: Saunders; 2004:512-22. 
  
6. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial 
fibrillation. A population-based study over three decades. N Engl J Med 1987;317:669-74. 
7. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in 
adults: national implications for rhythm management and stroke prevention: the 
AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 
2001;285:2370-5. 
8. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age 
distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch 
Intern Med 1995;155:469-73. 
9. Padanilam B, Prystowsky EN. Epidemiology of Atrial Fibrillation. The Rising 
Prevalence. In: Natale A, Jalife J, eds. Atrial Fibrillation From bench to bedside. Totowa: 
Humana Press; 2008:3-11. 
10. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of 
atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. 
Am J Med 1995;98:476-84. 
11. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke 
in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-4. 
12. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial 
fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6. 
  
13. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms 
and clinical implications. Pacing Clin Electrophysiol 1996;19:95-106. 
14. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation 
by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66. 
15. Berenfeld O, Zaitsev AV, Mironov SF, Pertsov AM, Jalife J. Frequency-dependent 
breakdown of wave propagation into fibrillatory conduction across the pectinate muscle 
network in the isolated sheep right atrium. Circ Res 2002;90:1173-80. 
16. Schuessler RB, Grayson TM, Bromberg BI, Cox JL, Boineau JP. Cholinergically 
mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right 
atrium. Circ Res 1992;71:1254-67. 
17. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant 
sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 
2000;101:194-9. 
18. Lazar S, Dixit S, Marchlinski FE, Callans DJ, Gerstenfeld EP. Presence of left-to-
right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. 
Circulation 2004;110:3181-6. 
19. Mansour M, Mandapati R, Berenfeld O, Chen J, Samie FH, Jalife J. Left-to-right 
gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. 
Circulation 2001;103:2631-6. 
  
20. Moe GK, Rheinboldt WC, Abildskov JA. A Computer Model of Atrial Fibrillation. 
Am Heart J 1964;67:200-20. 
21. Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a 
mechanism of tachycardia. III. The "leading circle" concept: a new model of circus 
movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 
1977;41:9-18. 
22. Rensma PL, Allessie MA, Lammers WJ, Bonke FI, Schalij MJ. Length of excitation 
wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 
1988;62:395-410. 
23. Cox JL, Schuessler RB, Boineau JP. The development of the Maze procedure for 
the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000;12:2-14. 
24. Nattel S, Shiroshita-Takeshita A, Brundel BJJM, Rivard L. Mechanisms of Atrial 
Fibrillation: Lessons From Animal Models. Progress in Cardiovascular Diseases 
2005;48:9-28. 
25. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S. Comparative 
mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of 
use-dependent effects on refractoriness. Circulation 1993;88:1030-44. 
26. Wang Z, Page P, Nattel S. Mechanism of flecainide's antiarrhythmic action in 
experimental atrial fibrillation. Circ Res 1992;71:271-87. 
  
27. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the 
enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial 
electrical remodeling. Circulation 1998;98:2202-9. 
28. Panfilov AV, Pertsov AM. [Mechanism of spiral waves initiation in active media, 
connected with critical curvature phenomenon]. Biofizika 1982;27:886-9. 
29. Winfree AT. Varieties of spiral wave behavior: An experimentalist's approach to the 
theory of excitable media. Chaos 1991;1:303-34. 
30. Comtois P, Kneller J, Nattel S. Of circles and spirals: bridging the gap between the 
leading circle and spiral wave concepts of cardiac reentry. Europace 2005;7 Suppl 2:10-20. 
31. Comtois P, Sakabe M, Vigmond EJ, et al. Mechanisms of Atrial Fibrillation 
Termination by Rapidly Unbinding Sodium Channel Blockers. Insights from Mathematical 
Models and Experimental Correlates. Am J Physiol Heart Circ Physiol 2008. 
32. Okishige K, Nishizaki M, Azegami K, Igawa M, Yamawaki N, Aonuma K. 
Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a 
placebo-controlled, multicenter study. Am Heart J 2000;140:e13. 
33. Wijffels MC, Dorland R, Mast F, Allessie MA. Widening of the excitable gap 
during pharmacological cardioversion of atrial fibrillation in the goat: effects of 
cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 2000;102:260-7. 
34. Kneller J, Kalifa J, Zou R, et al. Mechanisms of atrial fibrillation termination by 
  
pure sodium channel blockade in an ionically-realistic mathematical model. Circ Res 
2005;96:e35-47. 
35. Nattel S, Kneller J, Zou R, Leon LJ. Mechanisms of termination of atrial fibrillation 
by Class I antiarrhythmic drugs: evidence from clinical, experimental, and mathematical 
modeling studies. J Cardiovasc Electrophysiol 2003;14:S133-9. 
36. Skanes AC, Mandapati R, Berenfeld O, Davidenko JM, Jalife J. Spatiotemporal 
periodicity during atrial fibrillation in the isolated sheep heart. Circulation 1998;98:1236-
48. 
37. Ikeda T, Uchida T, Hough D, et al. Mechanism of spontaneous termination of 
functional reentry in isolated canine right atrium. Evidence for the presence of an excitable 
but nonexcited core. Circulation 1996;94:1962-73. 
38. Kneller J, Zou R, Vigmond EJ, Wang Z, Leon LJ, Nattel S. Cholinergic atrial 
fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with 
realistic ionic properties. Circ Res 2002;90:E73-87. 
39. Jalife J, Berenfeld O. Dominant frequency mapping to assess the consequences of 
remodeling in the mechanism of atrial fibrillation. In: Natale A, Jalife J, eds. Atrial 
fibrillation: from bench to bedside. Totowa: Humana Press; 2008:77-100. 
40. Jalife J, Berenfeld O, Mansour M. Mother rotors and fibrillatory conduction: a 
mechanism of atrial fibrillation. Cardiovasc Res 2002;54:204-16. 
  
41. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. 
Structural, functional, and electrophysiological characteristics of a new model of sustained 
atrial fibrillation. Circulation 1995;91:1588-95. 
42. Haissaguerre M, Sanders P, Hocini M, et al. Changes in atrial fibrillation cycle 
length and inducibility during catheter ablation and their relation to outcome. Circulation 
2004;109:3007-13. 
43. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of 
pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 
2000;102:2619-28. 
44. Harada A, Konishi T, Fukata M, Higuchi K, Sugimoto T, Sasaki K. Intraoperative 
map guided operation for atrial fibrillation due to mitral valve disease. Ann Thorac Surg 
2000;69:446-50; discussion 50-1. 
45. Berenfeld O. Quantifying activation frequency in atrial fibrillation to establish 
underlying mechanisms and ablation guidance. Heart Rhythm 2007;4:1225-34. 
46. Sanders P, Berenfeld O, Hocini M, et al. Spectral analysis identifies sites of high-
frequency activity maintaining atrial fibrillation in humans. Circulation 2005;112:789-97. 
47. Lazar S, Dixit S, Callans DJ, Lin D, Marchlinski FE, Gerstenfeld EP. Effect of 
pulmonary vein isolation on the left-to-right atrial dominant frequency gradient in human 
atrial fibrillation. Heart Rhythm 2006;3:889-95. 
  
48. Atienza F, Almendral J, Jalife J, et al. Real-time dominant frequency mapping and 
ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency 
gradients predicts long-term maintenance of sinus rhythm. Heart Rhythm 2009;6:33-40. 
49. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of 
atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 
2004;43:2044-53. 
50. Rostock T, Rotter M, Sanders P, et al. High-density activation mapping of 
fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart 
Rhythm 2006;3:27-34. 
51. Verma A, Novak P, Macle L, et al. A prospective, multicenter evaluation of ablating 
complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an 
automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy. 
Heart Rhythm 2008;5:198-205. 
52. Kalifa J, Tanaka K, Zaitsev AV, et al. Mechanisms of wave fractionation at 
boundaries of high-frequency excitation in the posterior left atrium of the isolated sheep 
heart during atrial fibrillation. Circulation 2006;113:626-33. 
53. Everett THt, Wilson EE, Verheule S, Guerra JM, Foreman S, Olgin JE. Structural 
atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a 
comparison in canine models of structural and electrical atrial remodeling. Am J Physiol 
Heart Circ Physiol 2006;291:H2911-23. 
  
54. Zlochiver S, Yamazaki M, Kalifa J, Berenfeld O. Rotor meandering contributes to 
irregularity in electrograms during atrial fibrillation. Heart Rhythm 2008;5:846-54. 
55. Nattel S. Complex fractionated atrial electrograms: can they be made simple? Heart 
Rhythm 2008;5:855-6. 
56. Lu Z, Scherlag BJ, Lin J, et al. Autonomic mechanism for complex fractionated 
atrial electrograms: evidence by fast fourier transform analysis. J Cardiovasc Electrophysiol 
2008;19:835-42. 
57. Katzung BG. Introduction to autonomic Pharmacology. In: Katzung BG, ed. Basic 
and Clinical Pharmacology. 10th ed: McGraw Hill 2007:75-93. 
58. Janes RD, Brandys JC, Hopkins DA, Johnstone DE, Murphy DA, Armour JA. 
Anatomy of human extrinsic cardiac nerves and ganglia. Am J Cardiol 1986;57:299-309. 
59. Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and 
variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 
2000;259:353-82. 
60. Kawashima T. The autonomic nervous system of the human heart with special 
reference to its origin, course, and peripheral distribution. Anat Embryol (Berl) 
2005;209:425-38. 
61. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and 
sinus and atrioventricular nodes. The third fat pad. Circulation 1997;95:2573-84. 
  
62. Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and 
microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec 
1997;247:289-98. 
63. Pauza DH, Skripka V, Pauziene N. Morphology of the intrinsic cardiac nervous 
system in the dog: a whole-mount study employing histochemical staining with 
acetylcholinesterase. Cells Tissues Organs 2002;172:297-320. 
64. Yuan BX, Ardell JL, Hopkins DA, Losier AM, Armour JA. Gross and microscopic 
anatomy of the canine intrinsic cardiac nervous system. Anat Rec 1994;239:75-87. 
65. Zhang Y, Mazgale T. Role of the vagus in AF. Pathophysiology and therapeutic 
applications. In: Natale A, Jalife J, eds. Atria Fibrillation From bench to bedside. Totowa: 
Humana Press; 2008:115-31. 
66. Rubart M, Zipes DP. Genesis of Cardiac Arrhythmias: Electrophysiological 
Considerations. In: Zipes DP, LIbby P, Bonow RO, Braunwald E, eds. Braunwald's Heart 
Disease A textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders; 
2005:653-87. 
67. Garrey WE. Auricular fibrillation. Physiol Rev 1924;4:215-50. 
68. Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc 
Electrophysiol 1996;7:999-1007. 
69. Wang J, Liu L, Feng J, Nattel S. Regional and functional factors determining 
  
induction and maintenance of atrial fibrillation in dogs. Am J Physiol 1996;271:H148-58. 
70. Smeets JL, Allessie MA, Lammers WJ, Bonke FI, Hollen J. The wavelength of the 
cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, 
autonomic transmitters, temperature, and potassium. Circ Res 1986;58:96-108. 
71. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in 
dogs: role of refractoriness heterogeneity. Am J Physiol 1997;273:H805-16. 
72. Pappone C, Santinelli V, Manguso F, et al. Pulmonary vein denervation enhances 
long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. 
Circulation 2004;109:327-34. 
73. Lemola K, Chartier D, Yeh YH, et al. Pulmonary vein region ablation in 
experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. 
Circulation 2008;117:470-7. 
74. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial 
fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-68. 
75. Ehrlich JR, Coutu P, Yeh YH, Qi X, Nattel S. Cellular Electrophysiology and the 
substrate for atrial fibrillation. In: Natale A, Jalife J, eds. Atrial fibrillation From bench to 
bedside. Totowa Humana Press; 2008:37-56. 
76. Nattel S, Burstein B, Dobrev D. Atrial Remodeling and Atrial Fibrillation: 
Mechanisms and Implications. Circ Arrhythmia Electrophysiol 2008;1:62-73. 
  
77. Opie L. Channels, pumps, and exchangers. In: Opie L, ed. Heart Physiology, from 
cell to circulation. 3rd ed. Philadelphia: Lippincot-Raven; 1998:71-114. 
78. Sun H, Chartier D, Leblanc N, Nattel S. Intracellular calcium changes and 
tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 
2001;49:751-61. 
79. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying 
action potential changes in a canine model of atrial fibrillation. Circ Res 1997;81:512-25. 
80. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S. Molecular mechanisms underlying 
ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999;84:776-84. 
81. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic 
mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 
1999;44:121-31. 
82. Schotten U, Duytschaever M, Ausma J, Eijsbouts S, Neuberger HR, Allessie M. 
Electrical and contractile remodeling during the first days of atrial fibrillation go hand in 
hand. Circulation 2003;107:1433-9. 
83. Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion-channel remodeling 
in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 
2007;87:425-56. 
84. Dobrev D, Graf E, Wettwer E, et al. Molecular basis of downregulation of G-
  
protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial 
fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic 
receptor-mediated shortening of action potentials. Circulation 2001;104:2551-7. 
85. Dobrev D, Wettwer E, Kortner A, Knaut M, Schuler S, Ravens U. Human inward 
rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 
2002;54:397-404. 
86. Cha TJ, Ehrlich JR, Zhang L, Chartier D, Leung TK, Nattel S. Atrial tachycardia 
remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential 
relation to arrhythmogenesis. Circulation 2005;111:728-35. 
87. Dobrzynski H, Marples DD, Musa H, et al. Distribution of the muscarinic K+ 
channel proteins Kir3.1 and Kir3.4 in the ventricle, atrium, and sinoatrial node of heart. J 
Histochem Cytochem 2001;49:1221-34. 
88. Shi H, Yang B, Xu D, Wang H, Wang Z. Electrophysiological characterization of 
cardiac muscarinic acetylcholine receptors: different subtypes mediate different potassium 
currents. Cell Physiol Biochem 2003;13:59-74. 
89. Shi H, Wang H, Li D, Nattel S, Wang Z. Differential alterations of receptor 
densities of three muscarinic acetylcholine receptor subtypes and current densities of the 
corresponding K+ channels in canine atria with atrial fibrillation induced by experimental 
congestive heart failure. Cell Physiol Biochem 2004;14:31-40. 
90. Brundel BJ, Van Gelder IC, Henning RH, et al. Ion channel remodeling is related to 
  
intraoperative atrial effective refractory periods in patients with paroxysmal and persistent 
atrial fibrillation. Circulation 2001;103:684-90. 
91. Brundel BJ, Van Gelder IC, Henning RH, et al. Alterations in potassium channel 
gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: 
differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol 
2001;37:926-32. 
92. Yeh YH, Qi X, Shiroshita-Takeshita A, et al. Atrial tachycardia induces 
remodelling of muscarinic receptors and their coupled potassium currents in canine left 
atrial and pulmonary vein cardiomyocytes. Br J Pharmacol 2007;152:1021-32. 
93. Dobrev D, Friedrich A, Voigt N, et al. The G protein-gated potassium current 
I(K,ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation 
2005;112:3697-706. 
94. Ehrlich JR, Cha TJ, Zhang L, et al. Characterization of a hyperpolarization-
activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein 
myocardial sleeves and left atrium. J Physiol 2004;557:583-97. 
95. Cha TJ, Ehrlich JR, Chartier D, Qi XY, Xiao L, Nattel S. Kir3-based inward 
rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial 
repolarization and arrhythmias. Circulation 2006;113:1730-7. 
96. Voigt N, Maguy A, Yeh YH, et al. Changes in I K, ACh single-channel activity 
with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res 
  
2008;77:35-43. 
97. Voigt N, Friedrich A, Bock M, et al. Differential phosphorylation-dependent 
regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in 
patients with chronic atrial fibrillation. Cardiovasc Res 2007;74:426-37. 
98. Michael G, Xiao L, Qi XY, Dobrev D, Nattel S. Remodelling of cardiac 
repolarization: how homeostatic responses can lead to arrhythmogenesis. Cardiovasc Res 
2009;81:491-9. 
99. Olgin JE, Sih HJ, Hanish S, et al. Heterogeneous atrial denervation creates substrate 
for sustained atrial fibrillation. Circulation 1998;98:2608-14. 
100. Jayachandran JV, Sih HJ, Winkle W, Zipes DP, Hutchins GD, Olgin JE. Atrial 
fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous 
changes in atrial sympathetic innervation. Circulation 2000;101:1185-91. 
101. Chang CM, Wu TJ, Zhou S, et al. Nerve sprouting and sympathetic 
hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial 
pacing. Circulation 2001;103:22-5. 
102. Goette A, Juenemann G, Peters B, et al. Determinants and consequences of atrial 
fibrosis in patients undergoing open heart surgery. Cardiovasc Res 2002;54:390-6. 
103. Thijssen VL, Ausma J, Borgers M. Structural remodelling during chronic atrial 
fibrillation: act of programmed cell survival. Cardiovasc Res 2001;52:14-24. 
  
104. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial 
fibrillation. J Am Coll Cardiol 2008;51:802-9. 
105. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure 
in dogs: atrial remodeling of a different sort. Circulation 1999;100:87-95. 
106. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling 
during atrial fibrillation. Cardiovasc Res 2002;54:230-46. 
107. Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S. Dynamic nature of atrial 
fibrillation substrate during development and reversal of heart failure in dogs. Circulation 
2002;105:2672-8. 
108. Cha TJ, Ehrlich JR, Zhang L, et al. Dissociation between ionic remodeling and 
ability to sustain atrial fibrillation during recovery from experimental congestive heart 
failure. Circulation 2004;109:412-8. 
109. Ausma J, van der Velden HM, Lenders MH, et al. Reverse structural and gap-
junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 
2003;107:2051-8. 
110. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the 
atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent 
and -independent pathways. Cardiovasc Res 2003;60:315-25. 
111. Hanna N, Cardin S, Leung TK, Nattel S. Differences in atrial versus ventricular 
  
remodeling in dogs with ventricular tachypacing-induced congestive heart failure. 
Cardiovasc Res 2004;63:236-44. 
112. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: 
rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation 
in vitro. Proc Natl Acad Sci U S A 1986;83:4167-71. 
113. Nakajima H, Nakajima HO, Salcher O, et al. Atrial but not ventricular fibrosis in 
mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ 
Res 2000;86:571-9. 
114. Olgin JE, Verheule S. Transgenic and knockout mouse models of atrial arrhythmias. 
Cardiovasc Res 2002;54:280-6. 
115. Xiao HD, Fuchs S, Campbell DJ, et al. Mice with cardiac-restricted angiotensin-
converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. 
Am J Pathol 2004;165:1019-32. 
116. Khairy P, Nattel S. New insights into the mechanisms and management of atrial 
fibrillation. Cmaj 2002;167:1012-20. 
117. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying 
tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 
1997;96:4027-35. 
118. Ortiz J, Niwano S, Abe H, Rudy Y, Johnson NJ, Waldo AL. Mapping the 
  
conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights 
into mechanisms. Circ Res 1994;74:882-94. 
119. Shiroshita-Takeshita A, Brundel BJ, Nattel S. Atrial fibrillation: basic mechanisms, 
remodeling and triggers. J Interv Card Electrophysiol 2005;13:181-93. 
120. Nattel S, Li D. Ionic remodeling in the heart: pathophysiological significance and 
new therapeutic opportunities for atrial fibrillation. Circ Res 2000;87:440-7. 
121. Sun H, Gaspo R, Leblanc N, Nattel S. Cellular mechanisms of atrial contractile 
dysfunction caused by sustained atrial tachycardia. Circulation 1998;98:719-27. 
122. Pandit SV, Berenfeld O, Anumonwo JM, et al. Ionic determinants of functional 
reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. 
Biophys J 2005;88:3806-21. 
123. Sharifov OF, Fedorov VV, Beloshapko GG, Glukhov AV, Yushmanova AV, 
Rosenshtraukh LV. Roles of adrenergic and cholinergic stimulation in spontaneous atrial 
fibrillation in dogs. J Am Coll Cardiol 2004;43:483-90. 
124. Gaspo R, Bosch RF, Bou-Abboud E, Nattel S. Tachycardia-induced changes in Na+ 
current in a chronic dog model of atrial fibrillation. Circ Res 1997;81:1045-52. 
125. Elvan A, Huang XD, Pressler ML, Zipes DP. Radiofrequency catheter ablation of 
the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in 
dogs. Circulation 1997;96:1675-85. 
  
126. Polontchouk L, Haefliger JA, Ebelt B, et al. Effects of chronic atrial fibrillation on 
gap junction distribution in human and rat atria. J Am Coll Cardiol 2001;38:883-91. 
127. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of 
atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79. 
128. Wilhelm M, Kirste W, Kuly S, et al. Atrial distribution of connexin 40 and 43 in 
patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ 
2006;15:30-7. 
129. Shinagawa K, Li D, Leung TK, Nattel S. Consequences of atrial tachycardia-
induced remodeling depend on the preexisting atrial substrate. Circulation 2002;105:251-7. 
130. Lammers WJ, Kirchhof C, Bonke FI, Allessie MA. Vulnerability of rabbit atrium to 
reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol 
1992;262:H47-55. 
131. Courtemanche M, Ramirez RJ, Nattel S. Ionic mechanisms underlying human atrial 
action potential properties: insights from a mathematical model. Am J Physiol 
1998;275:H301-21. 
132. Harrild D, Henriquez C. A computer model of normal conduction in the human 
atria. Circ Res 2000;87:E25-36. 
133. Gong Y, Xie F, Stein KM, et al. Mechanism underlying initiation of paroxysmal 
atrial flutter/atrial fibrillation by ectopic foci: a simulation study. Circulation 
  
2007;115:2094-102. 
134. Sarmast F, Kolli A, Zaitsev A, et al. Cholinergic atrial fibrillation: I(K,ACh) 
gradients determine unequal left/right atrial frequencies and rotor dynamics. Cardiovasc 
Res 2003;59:863-73. 
135. Takahashi Y, Jais P, Hocini M, et al. Shortening of fibrillatory cycle length in the 
pulmonary vein during vagal excitation. J Am Coll Cardiol 2006;47:774-80. 
136. Sharifov OF, Zaitsev AV, Rosenshtraukh LV, et al. Spatial distribution and 
frequency dependence of arrhythmogenic vagal effects in canine atria. J Cardiovasc 
Electrophysiol 2000;11:1029-42. 
137. Kovoor P, Wickman K, Maguire CT, et al. Evaluation of the role of I(KACh) in 
atrial fibrillation using a mouse knockout model. J Am Coll Cardiol 2001;37:2136-43. 
138. Schauerte P, Scherlag BJ, Pitha J, et al. Catheter ablation of cardiac autonomic 
nerves for prevention of vagal atrial fibrillation. Circulation 2000;102:2774-80. 
139. Arora R, Ulphani JS, Villuendas R, et al. Neural substrate for atrial fibrillation: 
implications for targeted parasympathetic blockade in the posterior left atrium. Am J 
Physiol Heart Circ Physiol 2008;294:H134-44. 
140. Huang CX, Zhao QY, Liang JJ, et al. Differential densities of muscarinic 
acetylcholine receptor and I(K,ACh) in canine supraventricular tissues and the effect of 
amiodarone on cholinergic atrial fibrillation and I(K,ACh). Cardiology 2006;106:36-43. 
  
141. Yamanushi TT, Shui Z, Leach RN, Dobrzynski H, Claydon TW, Boyett MR. Role 
of internalization of M2 muscarinic receptor via clathrin-coated vesicles in desensitization 
of the muscarinic K+ current in heart. Am J Physiol Heart Circ Physiol 2007;292:H1737-
46. 
142. Pfaffinger PJ, Martin JM, Hunter DD, Nathanson NM, Hille B. GTP-binding 
proteins couple cardiac muscarinic receptors to a K channel. Nature 1985;317:536-8. 
143. Scherlag BJ, Nakagawa H, Jackman WM, et al. Electrical stimulation to identify 
neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol 
2005;13 Suppl 1:37-42. 
 
 
 
